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ABSTRACT 
The purpose of this study was to conduct perceptual analyses, using the initial two-
second portions, of prolonged vowels /a/, /i/, and /o/.  Two groups of adolescents and young 
adults were analyzed- one group consisting of 20 individuals with Friedreich’s ataxia who were 
compared to 20 individuals with normal voice (control participants).  A trained group of 10 
graduate students listened to 132 vowel samples (3 vowels X 40 participants, + 12 samples 
(10%) for reliability purposes) for a total of 132 perceptual judgments.  The students listened to 
the samples which were randomized onto Dell computers (Optiplex 755) and played through 
headphones that were set at a comfortable level by the listeners prior to analyzing the voice 
samples.  Listeners used a modified version of the Consensus-Auditory Perceptual Evaluation of 
Voice (CAPE-VM) to rate the vocal qualities of ‘roughness’, ‘breathiness’, and ‘strain’ in the 
samples on a 100 millimeter visual analog scale with 0 representing a perception of no 
roughness, breathiness, or strain, and 100 indicating the most extreme amount of variance from 
normal voice quality.   
Statistical analyses were conducted to determine if perceptual measures were 
significantly different between the two groups.  Values on these analyses were expected to be 
larger for individuals with Friedreich’s ataxia than those with normal voice.  Results revealed 
that all three measures were significantly different between the two groups, with those in the 
Friedreich’s ataxia group reported as having increased rough, breathy, and strained components 
in their voice quality as compared to normal voiced peers.  Findings support perceptual measures 
as useful indicators for reporting changes in the phonatory system due to Friedreich’s ataxia. 
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CHAPTER 1 
INTRODUCTION  
 
Friedreich’s ataxia (FA) is a hereditary, neurodegenerative, rare disease that affects 
genders equally.   It impacts the nervous system which gives rise to movement problems. 
Neuronal degeneration occurs in individuals with FA, which is why the nervous system is 
affected.  Although the disease itself is rare, it is a fairly common disorder among the ataxias. 
Ataxia occurs when there’s a failure in coordination of the muscles as well as muscular activity 
irregularity. About 50% of all cases of hereditary ataxia are comprised of Friedreich’s ataxia.  In 
regards to prevalence, it is the most prevalent inherited ataxia affecting about 1/50,000 
individuals (Cossee et al., 1999).  The disease is an autosomal recessive, inherited, degenerative 
disease. In order for an individual to be affected, it is necessary to receive the gene from both 
parents making it an autosomal recessive genetic disorder.  Incidence of this disease is around 
1.5 per 100,000 per year among Europeans and North Americans of European 
descent.  Typically, the onset occurs around puberty, but it can strike as young as 5 years of age 
(National Institute of Neurological Disorders and Stroke, 2011). The mean age of death is around 
32 years.  There is also an adult onset form which can occur anytime during adulthood; however, 
disease progression is faster in the childhood form.  
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A Review of the Literature: 
 
Description of FA 
 
Frataxin (FXN) is an important mitochondrial protein-located on chromosome 9.  FXN 
helps to move iron and is essentially part of the production of energy.  Frataxin is found in 
prokaryotes and eukaryotes and required for regulation of cellular iron homeostasis (Bencze et 
al., 2006).   In FA, the defective gene, Frataxin, is reduced thus, less energy is available to cells, 
especially peripheral nerve, spinal cord, brain, and heart muscle cells (National Institute of 
Neurological Disorders and Stroke, 2011).   Specifically, the FXN mutation consists of a 
homozygous guanine-adenine-adenine (GAA) trinucleotide repeat (Rajeswari, 2012).  A normal 
human karyotype should have around 6 to 36 copies of GAA; whereas, individuals with FA can 
have between 90 to 1,300 copies on chromosome 9 (Cossee et al., 1999).  A positive correlation 
has been found between the number of GAA copies and disease onset and progression; the more 
copies present, the earlier the disease will occur and the quicker it will progress (Metz, 2013). 
 
Symptoms 
 
In FA, a gradual loss of strength in the musculature of the arms and legs, stiffness of the 
muscles, and speech impairments occur.  The central and peripheral nervous systems, heart, 
skeleton, and pancreas are all affected.  Physical features of FA are ongoing, usually appearing 
around puberty. Common initial symptoms are poor balance, slurred speech, and dysphagia 
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(Pandolfo, 2009).  Later characteristics of the disease can include visual impairments, hearing 
abnormalities, weakness and balance/coordination difficulties involving the arms and legs, 
scoliosis of the spine, disorders of the heart, and diabetes (Brice, 2004).  
FA affects an individual’s speech and voice production due to changes in neural control 
of muscles.  Differential subsystem impairment occurs with this disease; thus, all individuals will 
not portray the same set of symptoms.  Disease features depend on which speech subsystems are 
affected (Folker et al., 2012).  For example, scoliosis and decreased respiratory drive of 
inspiratory muscles can result in reduced inspiratory volume and diminished subglottal air 
pressure available for speech.   A harsh or strained-strangled vocal quality has been noted, likely 
due to increased muscle tone (spasticity) in phonatory muscles necessary for normal voice 
production or due to compensatory adjustments at the level of the glottis related to reduced 
subglottic pressure (Folker et al., 2010).  Individual variability reported in the literature is shown 
in phonetic profiles across subjects with FA (Blaney & Hewlett, 2007).  Other perceptual speech 
and/or voice features reported in FA include hypernasality, variations in pitch and loudness, 
problems in breath support for speech, stress issues, breathiness, roughness, glottal fry, 
phonation breaks, tremor, and pitch breaks (Folker et al.,2010; Folker et al., 2012).  These 
characteristics are associated mainly with laryngeal dysfunction, and to a lesser degree with 
velopharyngeal dysfunction.   Furthermore, irregular articulatory breakdowns, prolonged 
phonemes, distorted vowels, and disturbed oral coordination have been reported (Folker et al., 
2010; Hertrich, 1997).  Prosody is also affected which results in the perception of monotone 
speech (Legge, 2010). 
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A hallmark symptom of FA is dysarthria (e.g., Blaney & Hewlett, 2007a); however, 
because the cerebellar pathways and/or cranial nerves can be affected, the type of dysarthria 
present varies from primarily ataxia dysarthria (e.g., coordinative problems) to mixed dysarthria 
involving combinations of ataxic/spastic/flaccid components with cerebral and cerebellar 
components.  There is evidence to suggest that the signs of the spastic and flaccid components 
vary across individuals and over time (Blaney & Hewlett, 2007a).  Thus, the dysarthria 
associated with FA has features in common with other forms of cerebellar degenerative diseases, 
but differs in the added features of variable spastic and flaccid elements.  In FA, neuronal 
degeneration has been found involving the motor cortex and cranial nerves (Botez et al., 1998).  
According to Blaney and Hewlett (2007a), speech symptoms in FA are not fully understood, but 
are likely due to the variable effects of the disease on speech subsystems and the progressive 
nature in which signs may change over the course of the disease (e.g., Folker et al, 2010; 
Joanette & Dudley, 1980).   Not only are perceptual speech dimensions important to support 
differential diagnosis, disease progression, speech subsystem involvement, and functionality of 
intervention, but they are useful for clinicians as they can form a common ground for 
communication. 
   
Perceptual Measures 
 
Acoustic characteristics of speech and voice in FA have received attention as potentially 
valuable indicators of disease progression, especially through later stages of the disease (Rosen 
et al., 2012). Considering the “Gold Standard” of clinical measurements related to speech and 
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voice characteristics is said to be perceptual ratings (Estella & Edwin, -nd), it seems necessary to 
take these measures into account, in addition to acoustical estimates, when documenting the 
effects of FA on speech and voice.  
  Perceptual ratings of vocal features are made from stimuli heard by a listener/observer; 
however, they are highly subjective, and can be subject to reliability problems (e.g. Kreiman, 
Gerratt, Kempster, Erman, & Berke, 1993).  In response to problems encountered by Speech 
Language Pathologists (SLPs) in documenting accurately abnormal voice features, members of 
ASHAs Divison 3, a special interest group of voice professionals/researchers, developed the 
Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) (Kempster, 2007; Kempster, 
Gerratt, Verdolini Abbott, Barkmeier-Kraemer & Hillman, 2009).  The CAPE-V allows SLPs to 
employ a standardized procedure for a wide variety of voice disorders that contains a small 
number of clinically meaningful features of voice (Kempster, 2007).   Another important 
criterion in the development and trial of the CAPE-V was that it should be as reliable as possible 
across clinical professionals and across the vast array of individuals presenting with voice 
problems.  When using the CAPE-V, individuals are required to prolong the vowels /a/ and /i/, 
read six sentences, and speak briefly about their voice problem.  The vowels /a/ and /i/ were 
selected based on a number of feature differences.  For example, /a/ is a lax vowel and /i/ is a 
tense vowel. The /i/ vowel is commonly used during videostroboscopy and its use during this 
prolongation task offers an auditory comparison to that produced during a stroboscopic exam 
(The American Speech-Language-Hearing Association, 2006).  Judgments are determined based 
on overall severity, roughness, breathiness, strain, pitch, and loudness.  Overall quality of an 
individual’s voice is also taken into consideration.  A visual analog scale is used for marking 
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perceptual estimates.  In terms of reliability, the CAPE-V has been reported to be a reliable and 
sensitive measure of voice (Karnell et al., 2007). 
A few studies have used perceptual measures in combination with acoustic estimates, to 
document the effects of FA on speech and voice. Since FA affects multiple speech subsystems to 
variable degrees (e.g., Folker et al., 2012), studies which included various neuropathologies 
representing a general form of ataxic dysarthria will not be discussed (e.g., Kent et al., 2000).  
Studies have varied greatly in terms of number and ages of participants, speech and voice 
measures collected, qualifications of listeners, rating scales used for perceptual estimates, and 
use of “normal” peers/controls for comparisons. Some of these variables were dictated by the 
research questions posed or by language (e.g., Brendel et al., 2013).  Participants included in 
studies of dysarthria in FA have ranged in age from as young as 16 to 71 years of age (Brendel et 
al., 2013), with most mean ages in the mid- to late 30’s or early 40’s (Blaney & Hewlett, 2007;  
Brendel et al., 2013; Folker et al., 2010; Folker et al., 2012; Rosen et al., 2012).  Number of 
participants has ranged from 7 (Folker et al., 2012) to 38 (Folker et al., 2010), with a mean of 21 
for the seven studies reviewed.   Speech samples have included conversational samples (Joanette 
& Dudley, 1980), reading of the Grandfather Passage (Folker et al., 2010; Folker et al., 2012; 
Rosen et al., 2012), the Assessment of Intelligibility of Dysarthria Speech (Folker et al., 2010), 
sustained phonation of the vowel /a/ (Brendel et al., 2013; Folker et al., 2012), and 
diadochokinetic tasks (Brendel et al., 2013; Singh, Epstein, Myers, Farmer, & Lynch, 2013).   
Listeners who have rated the speech samples have varied from untrained undergraduate 
students who were majoring in “speech and language therapy” (Blaney & Hewlett, 2007) to two 
SLPs (Folker et al., 2010; Folker et al. 2012; Rosen et al., 2012), or the authors plus a graduate 
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student (Joanette & Dudley, 1980).  It should be noted that the undergraduate students who 
served as listeners in the Blaney and Hewlett study were only required to determine what word 
they heard chosen from a list of four, after hearing recorded single-word productions from male 
participants who had a clinical diagnosis of FA. In terms of perceptual scales used in studies of 
FA dysarthria, studies by Folker and associates (including Rosen et al., 2012) have used a 
perceptual rating scale that included 30 different dimensions modeled after Darley, Aronson, and 
Brown (1975). 
   
Purpose 
 
The purpose of this research study was to determine if a limited array of perceptual 
features rated by trained listeners from the first 2 seconds of prolonged vowel samples using a 
modified version of the CAPE-V (CAPE-VM) scaling system could differentiate between 1.) 
Individuals with FA and 2.) Gender matched and age-equivalent peers who were non-
neurologically impaired.  A secondary purpose of the study was to determine if trained listeners 
could determine speaker gender, what vowel was produced, and if the voice sample sounded 
disordered or non-disordered.  Lastly, the study sought to establish if there was a relationship 
between the three voice attributes measured by CAPE-VM results.  
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Justification 
 
 The CAPE-V serves many purposes, one of which is to describe vocal characteristics that 
can be easily communicated and understood by clinicians and other professionals.  Another 
purpose of the CAPE-V is to gain information on anatomy and physiology related to voice 
problems and to evaluate the need for additional testing (American Speech-Language Hearing 
Association, 2002-2006).  Therefore, based on the aforementioned benefits of the CAPE-V, it 
was used in this study in a somewhat modified form.  Listeners were required to rate only three 
voice parameters on the CAPE-V, namely, roughness, breathiness, and strain.  This modified 
version was labeled CAPE-VM.  Three features were used in order to decrease listener fatigue by 
decreasing the amount of time required to complete the listening task.  Further, these vocal 
characteristics were considered to be likely affected by FA (Folker et al., 2010; Folker et al., 
2012). 
 
Hypotheses 
 
It was hypothesized that differences would be found on ratings of roughness, breathiness, 
and strain between the two groups (NV/FA).  Specifically, listeners were expected to rate the FA 
voices as containing more roughness, breathiness, and/or strain as compared to those who had 
normal voices (NVs).  Further, it was predicted that the listeners would have a more difficult 
time determining which vowel was heard due to possible effects of FA that could lead to vowel 
distortion.  Listeners were asked to indicate the gender of participants; however, no predictions 
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were made on the outcome. Further, it was expected that the listeners would be able to determine 
which vowel samples were disordered or non-disordered when given a forced choice.   Lastly, it 
was predicted that the three voice attributes measured on the CAPE-VM would be highly 
correlated. 
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CHAPTER 2 
METHOD 
 
Study Design 
 
This study represented a mixed model between a prospective and descriptive design.  The 
study was designed to analyze the differences between two groups, individuals with FA, and 
normal voiced individuals. Group differences and relationships were determined by analyzing 
the listeners’ rating scores and noting  if there were differences between rating scores recorded 
from the two groups of voice samples: disordered and normal.  A specific “comparative” 
descriptive design was used to measure the behavior of two or more types of subjects at one 
point in time. Researchers drew conclusions about what the listeners’ scores revealed about the 
two groups.  
 
Variables 
 
In this research study, there was one independent variable (IV) and six dependent 
variables (DV).  The IV was group; whereas, the DVs included CAPE-VM measures of 
roughness, breathiness, and strain and perceptions of what vowel was heard, gender of speaker, 
and whether the voice heard represented a disordered or normal voice. 
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Participants diagnosed with Friedrich’s ataxia 
 
            Samples of vowel productions from individuals diagnosed with FA were collected by Dr. 
Marie Le Normand in Paris, France through a Marantz recorder.  Medical records were used to 
confirm the diagnosis of FA.  Note that participants in the present study were part of a larger 
study with patients recruited from all over the country of France and referred by physicians for a 
possible diagnosis of FA.  The larger study was supported by a pharmaceutical company and the 
equivalent of France’s National Institute of Health- Institut National de la Santé Et de la 
Recherche Medicale with an interest in making sure they were not treating patients who did not 
have FA.  Participants in France were recruited and recorded in accordance with existing policies 
regarding human subject participation in that country.  Participants in the present study included 
20 FA individuals, 10 females and 10 males with a mean age of 18.5 years (SD= 3.7; R= 10-25 
years old (see Table 1). 
 
Participants who had normal speech and voice (NV) 
 
After approval by the Institutional Review Board (IRB) at the University of Central 
Florida (UCF), potential participants were recruited by putting flyers in the Communication 
Sciences and Disorders (CSD) Department on the UCF campus, announcing the need for 
participants in the CSD classes along with a brief description of the recording task, as well as 
recruiting through online social networks which explained the study and what was needed from 
the participants.  Twenty young adults, 10 males and 10 females, who were between the ages of 
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18-25 (M=20.7, SD= 2.2 years) were selected.  Participants met the following criteria: (1) 
normal speech and voice with no medical history of speech or voice disorders, (2) native English 
speakers, (3) normal hearing as verified by either an audiometric pure tone screening or self-
report of having passed a hearing screening within the past two years, (4) no history of smoking, 
and (5) overall good health at the time of recording determined by self-report.  Gender and age of 
potential participants was considered when selecting among potential participants in an attempt 
to assure age equivalency and gender match with participants who were diagnosed with FA.  Age 
was significantly different between the two groups, with those in the FA group being younger 
than those in the NV group (t (38) = -2.29, p <.05). 
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Table 1: Participant Characteristics 
Descriptive Information of Participants with Friedreich’s Ataxia and Normal Voice, including 
age and gender. 
______________________________________________________________________________ 
Group                                                      Age                                           Gender 
_______________________________________________________________________________ 
FA03                                                         17                                              Female 
FA06                                                         17                                              Female 
FA07                                                         16                                              Male 
FA08                                                         22                                              Female 
FA09                                                         13                                              Male 
FA10                                                         23                                              Female 
FA11                                                         19                                              Female 
FA12                                                         25                                             Female 
FA13                                                          21                                            Female 
FA17                                                          10                                            Male 
FA18                                                          20                                            Female 
FA19                                                          24                                            Female 
FA20                                                          20                                            Male 
FA22                                                          19                                            Male  
FA23                                                          16                                            Male 
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______________________________________________________________________________ 
Group                                                        Age                                           Gender 
_____________________________________________________________________________ 
FA25                                                          16                                            Female 
FA27                                                          16                                            Male  
FA29                                                          17                                            Male 
FA30                                                          18                                            Male  
FA33                                                          21                                            Male 
NV01                                                         24                                            Female 
NV02                                                         21                                            Female 
NV03                                                         19                                            Female  
NV04                                                         24                                            Female  
NV05                                                         22                                            Female 
NV06                                                         20                                            Female 
NV07                                                         22                                            Female 
NV08                                                         25                                            Female 
NV09                                                         21                                            Male 
NV10                                                         21                                            Male 
NV11                                                         20                                            Male 
NV12                                                         18                                            Female 
NV13                                                         19                                            Female 
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______________________________________________________________________________ 
Group                                                        Age                                           Gender 
_____________________________________________________________________________ 
NV14                                                         20                                            Male 
NV15                                                         18                                            Male 
NV16                                                         21                                            Male 
NV17                                                         18                                            Male 
NV18                                                         18                                            Male  
NV19                                                         19                                            Male  
NV20                                                         23                                            Male 
______________________________________________________________________________ 
Note 1. FA= Friedreich’s ataxia; NV= normal voice. 
 
15 
 
Listeners 
 
After recruiting individuals whose voices were recorded, the researchers then sought 10 
individuals who were going to serve as raters of the voice samples.  The listener group consisted 
of 10 trained raters who had the following credentials: they (1) needed to be CSD graduate 
students at the UCF, (2) have had, or were taking, the graduate course “Voice Disorders” 
SPA6221, (3) have had their hearing checked within the past two years with no known, ongoing, 
hearing issues, and (4) were not friends or acquaintances of the researchers.  The 10 listeners 
were all female, ages between 21 and 30.  The graduate students were recruited by word of 
mouth within the department.  The 10 selected to be part of the study had a consent form 
provided to them, with the study explained in depth as well as what was expected of them, 
specific dates, times, and what benefits they might expect.  A one hour training on the CAPE-V 
was provided to the listening group by Bari Hoffman-Ruddy PhD-CCC-SLP, a professor who 
specialized in voice disorders at UCF’s CSD program.  Dr. Hoffman-Ruddy teaches the graduate 
level course in voice disorders and maintains an active research agenda and clinical voice 
practice.  She explained the CAPE-V, why it is used, how it is used, and offered feedback for any 
questions the raters had.  The time elapsed between the training and experimental condition was 
no more than five days. 
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Institutional Review Board (IRB) 
 
Prior to taking part in the study, each participant (i.e., those who would serve in the NV 
group and those who were listeners/raters) read the informed consent which was first approved 
by the IRB at UCF.  As per the IRB instructions, the participants were asked to verbally express 
their consent before proceeding with the study.  The participants were told they were able to 
leave the study at any time without penalty, and that they were not required to partake in the 
study.  Data collection documents, including the CAPE-VM , and a one page questionnaire on 
which the listeners indicated what vowel they perceived was spoken, whether they felt that the 
speaker had a distorted or non-distorted voice, and their estimation of the speaker’s gender.  
Those individuals whose voices (n=20) were recorded and the group of listeners (n=10) were 
provided with separate consent forms explaining their role in the study.  The consent forms were 
provided to explain to the participants the criteria for being included in the study, what was 
expected of them, specific timelines, privacy aspects, and benefits for participating  
 
Vowel Stimuli 
 
Recorded data collected in France from those in the FA group and used in the present 
study included production of sustained vowels /a/, /i/, and /o/ using a “normal pitch” recorded 
into a Marantz at 22.5Khz using an external microphone.  This recording order was maintained 
throughout data collection.  For the present study, productions of /a/, /i/, and /o/ were selected 
from the recordings made in France and used for further analysis and comparisons.  These three 
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vowels were selected because of contrasting tongue heights and advancement.  Vowel tongue 
height may be an indicator of the severity of vocal disorders as a relationship between vowel 
roughness and vocal tract configuration has been reported.  Vowels produced with the tongue 
placed lower in the oral cavity may result in greater roughness when compared to vowels 
produced with higher tongue positions (e.g., Sansone & Emanuel 1970).  The vowels /a/, /i/, and 
/o/ have different tongue heights in the oral cavity, as shown by the vowel quadrilateral in Figure 
1, with /a/ representing low tongue height. 
 
i high 
 
 o 
 
front 
 
 
                                  a low 
Figure 1: Modified Vowel Quadrilateral depicting tongue placement for the vowel sounds /a/ /i/ 
and /o/ used in this study. 
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Methods used to collect data from participants in the NV group were comparable with 
those used in France.  Participants in the NV group were asked to sustain the vowels of /a/, /i/ 
and /o/ for as long as possible while using a normal pitch.  Samples were recorded on a Roland 
Edirol (R-09HR) through an internal microphone (20-40KHz frequency response) while 
maintaining a mouth-to-microphone distance of 12 inches and digitized with a sampling rate of 
44kHz.  Voice samples were recorded in a quiet room located in UCF’s College of Health and 
Public Affairs Department. 
The 120 vowel samples (3vowels X 40 speakers) were dubbed onto a Dell (Optiplex 755) 
laboratory computer in the Speech Science Lab from the Edirol SD card using Brown Laboratory 
Interactive Speech System, Mertus, 19x (Bliss) software.  Samples collected in France were 
input into Bliss using a sample rate of 22.5KHz (i.e., the rate of sampling when collected in 
France); whereas, vowel samples recorded from participants in the NV group were input using a 
44KHz sample rate (i.e., sample rate of the Edirol).  Although the sampling rate between the two 
groups differed, this did not cause an issue throughout the study.  The nyquist sampling theorem 
states that the sampling frequency should be at least twice the highest frequency contained in the 
signal, which would make the sampling rates sufficient to capture each peak and trough of the 
signal (Olshausen, 2000). 
Each vowel was time expanded so that the first 2000 milliseconds (ms) from the first 
recognizable waveform could be selected and copied into a file.  Out of the 120 samples, 12 or 
10% were randomly selected for reliability purposes.  All 132 samples (3 vowels X 40 speakers 
X 10% reliability samples) were placed in a randomized order and saved.  The randomized order 
was done to eliminate possible listener bias.  Each of the 132 samples were saved on separate 
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files and identified by alphabet letters, beginning with “A”, “AA”, “AAA”, “AAAA”, “B”, etc.  
Rating of the samples was done in a one-time session.  Listeners selected single files shown on 
the computer screen (Dell Optiplex 755) in the order that was provided and rated those using the 
CAPE-VM and indicated judgments of gender, vowel perceived, and whether the voice was 
disordered or non-disordered in the sample.  They had the option of listening to each sample up 
to three times.  
The onset portion of the vowel was utilized in this study based on several factors.  First, 
the initial 500 ms of phonation represents an unstable period of vocal fold vibration.  It was 
reasoned that this unstable period might be more unstable in those with FA as compared to NV 
peers, thus giving the listeners perceptual cues that might not be readily apparent in the mid-
portion of a prolonged vowel.  Secondly, individuals with FA have a compromised respiratory 
system which affects their ability to phonate for longer periods of time due to decreased 
subglottal air pressure (Folker et al., 2010); thus, the vowel prolongation might not be long 
enough to select a 2-second mid-portion.  Lastly, the researchers wanted the listeners to rate the 
samples on voice quality characteristics while not being influenced by the length in time of each 
prolongation. 
 
Perceptual Data 
 
 The listening task involved listeners rating the 132 tokens.  Standardized instructions 
were read to the listeners and questions were answered.  The samples of prolonged vowels were 
presented through Sennheiser (HD 201) stereo headsets, with a loudness level that was self-set at 
20 
 
a comfortable level by the listeners before they started analyzing the voice samples.  The samples 
were played through Dell computers (Optiplex 755) in the CSD Speech Science lab.  It should be 
noted that all lab computers were the same model and had the same A-D cards.  The lab was 
located in a quiet room within the department.  As described previously, the rating form included 
perception of the gender of the speaker, whether the speaker had a non-disordered or disordered 
voice, what vowel was heard, and an estimation of roughness, breathiness, and strain using the 
CAPE-VM.  The form included a 100 millimeter line for each attribute on which listeners 
recorded their perception of deviance from normal of the attribute by placing a “tic” mark.  
General regions were indicated beneath the line and labeled “MI” or “mildly deviant”, “MO”, or 
“moderately deviant” and “SE” or “severely deviant”.  Data collected from the CAPE-VM 
consisted of measuring the length in millimeters from the start of the line to the “tic”. 
 Data on perceptions of gender, vowel produced, and diagnosis (whether the speaker had a 
disordered or non-disordered voice) were coded with “1” for a judgment that was correct and “0” 
for estimates that were incorrect. 
 
Statistical Analysis 
  
Descriptive statistics including mean and standard deviations were calculated to describe 
voice attributes and listener perceptions of gender, vowel, and diagnosis (disordered/non-
disordered voice).  Differences on the measures of roughness, breathiness, and strain recorded 
from CAPE-VM results were determined using one-way analysis of variance (ANOVA) tests.  
When variances were significantly different using Levine’s test for homogeneity of variance (2-
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tailed), t-tests for unequal variances were conducted.  Pearson correlations were performed to 
ascertain the relationships among the voice attributes.  A probability level of p < .05 was 
established for all statistical tests. 
 Inter-rater reliability (Chronbach’s Alpha) was calculated using the 12 reliability samples 
using the three CAPE-VM measures.  A reliability score of .88 was reported which indicated 
internal consistency just below excellent (.90) (Mason, Lind & Marchal, 1983). 
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CHAPTER 3 
RESULTS 
 
Group Differences on Voice Attributes 
 
 Table 2 depicts the group means and standard deviations recorded on the CAPE-VM for 
measures of roughness, breathiness, and strain.  An ANOVA and two t-tests for unequal 
variances were performed on the three voice attributes by group.  Results revealed significantly 
larger values for those who had FA as compared to NV peers.  Listeners perceived those in the 
FA group as having greater amounts of roughness, breathiness, and strain in their production of 
vowels than those in the NV group.  All of the listeners’ individual perceptual measures for these 
variables can be found in Appendix H. 
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Table 2: Statistical Comparisons of Normal Voice Individuals and Friedreich’s Ataxia 
Individuals on Measures of a Modified Consensus Auditory Perceptual Evaluation of Voice 
(CAPE-VM) in millimeters.  
 
CAPE-VM 
Measures                 NV                         FA                           df            F value         t value 
 
 
 
Roughness         10.12 (8.00)           18.29 (5.26)                 1,38          14.58** 
Breathiness        6.32 (3.51)             15.66 (8.45)                25.38                              4.57** 
Strain                 9.02 (5.73)             22.74 (9.60)                31.02                              5.49** 
 
Note 1.NV= normal voice; FA= Friedreich’s ataxia; df= degrees of freedom.  Values are 
expressed as means and (standard deviations) in millimeters. 
Note 2. Higher scores on all measures indicate a greater amount of the specific voice feature 
perceived. 
Note 3. **p≤.001, 2-tailed. 
 
Group Differences on Vowel, Disordered/Normal Voice, and Gender Perception 
 
 Descriptive statistics were used to determine how well listeners correctly identified 
vowels that were produced, gender, and diagnosis (i.e., disordered versus non-disordered voice) 
between participants in the NV and FA groups.   Measures can be found in Table 3. 
 Overall, listeners were mostly accurate in identifying which vowel was produced and 
gender of the speaker in both groups.  In contrast, distinguishing if a speaker had a normal (non-
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disordered) or disordered voice was a more difficult task as indicated by the lower means and 
higher standard deviations as contrasted to the perceptions of vowel heard and gender.  Their 
estimates were more accurate for those who had normal voices on all vowels as compared to 
those in the FA group.  Generally, listeners had the most agreement and least amount of variation 
in their judgments on perceiving gender for those who were in the NV group.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
Table 3: Group Comparison on Measures of Listener Ability to Correctly Identify Vowels, 
Diagnosis, and Gender. 
 
Measures       NV                                             FA                           
 
 
Vowel  
/a/     9.85 (.36)       9.25 (.85) 
/i/     9.25 (-.55)              9.30 (.47) 
/o/                8.20 (2.71)    8.90 (1.07) 
Diagnosis 
/a/      6.90 (2.49)    6.05 (2.26) 
/i/     7.70 (1.78)              5.50 (2.59) 
/o/      6.95 (2.42)    6.50 (2.12) 
Gender 
/a/     9.75 (.41)   8.70 (2.87) 
/i/     9.95 (.22)    8.45 (2.84) 
/o/     9.60 (.60)   8.60 (2.85) 
 
 
Note 1.NV= normal voice; FA= Friedreich’s ataxia; Values are expressed as means (standard 
deviations) out of a mean of 10 possible. 
Note 2. Lower scores on all measures indicate poorer ability to correctly identify the percept of 
interest.  
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Correlations on CAPE-VM Measures 
 
 Correlations between the three measures on the CAPE-VM were conducted using 
Pearson Correlations (2-tailed).  All measures were positively and significantly correlated at the 
0.01 level.  Breathiness correlated with roughness (r=.66), strain correlated with roughness 
(r=.78) and strain correlated with breathiness (r=.75).  Results indicated a moderate positive 
linear relationship between breathiness and roughness, and strong or high positive linear 
relationships between strain and roughness as well as strain and breathiness (Mason, Wong, & 
Entwisle, 1993).   
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CHAPTER 4 
DISCUSSION 
 
 The purpose of this study was to investigate the perceptual voice differences between 20 
individuals (10 males, 10 females) who had normal voice and 20 individuals (10 males, 10 
females) with Friedreich’s ataxia.   The stimuli consisted of the first 2000 ms of the vowels /a/, 
/i/, and /o/.  Trained listeners were asked to rate vocal quality on three characteristics of voice, 
roughness, breathiness, and strain using a modified version of the CAPE-V, as well as indicate 
the gender, vowel heard, and whether the voice was disordered or non-disordered. 
 Measures of vocal quality (roughness, breathiness, and strain) while sustaining the 
vowels /a/, /i/, and /o/ were found to be higher for individuals with Friedreich’s ataxia than for 
individuals with normal voice.  Therefore, as hypothesized, listeners rated the Friedreich’s ataxia 
voice samples more negatively on the CAPE-VM measures than the normal voice samples.  This 
finding supports previous work by Folker et al. (2010) who found that listeners rated speakers 
with FA as having more strain and stress in their voices when reading “The Grandfather 
Passage” as compared to speakers with normal voices.   
 Further, our results provide preliminary support for the use of the perceptual attributes of 
roughness, breathiness, and strain to distinguish adolescents and young adults with FA from 
young adult peers who are non-neurologically involved.  It was interesting to note that although 
the listeners perceived higher levels of the three attributes in those who had FA, they were only 
moderately accurate in estimating if the speaker had a voice that was disordered or non-
disordered.  The overall rating of diagnosis seemed to be a more difficult percept than estimating 
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singular voicing characteristics as shown by the mean and standard deviation of accuracy rates, 
and might have been expected given that those in the FA group were perceived as having, on 
average, ratings on the CAPE-VM in the mild to moderately deviant range (i.e., @ 16-23 mm, 
Table 2). 
  Further, it would seem logical that the voices of adolescents and young adults with FA 
might be only mildly affected, since dysarthria usually develops late in the disease (Eigentler et 
al., 2011). 
 In one of the few longitudinal studies on changes that occur during FA disease 
progression, Rosen et al. (2012) assessed participants once per year over a four year period.  
Results revealed three acoustic measures that depicted subtle changes in the acoustic signal when 
comparing between two consecutive year intervals.  The authors felt that acoustic measures were 
more sensitive than perceptual measures to subtle changes that occurred due to disease 
progression to those with FA in their study, stating that listeners may not be able to detect slight 
alterations in the acoustic signal that were identified by acoustic measures.  It should be noted, 
however, that listeners in the Rosen at al. study were asked to rate overall severity using Direct 
Magnitude Estimation.  It could be that perceptual evidence was available within each 
comparison 2-year period, but was not realized due to the use of an overall severity rating, rather 
than having listeners estimate specific voice characteristics.  As stated previously, listeners in 
this study weren’t very accurate when given the forced choice of indicating whether the voice 
sample was disordered or non-disordered, a rating somewhat similar to overall severity, even 
though subtle differences between groups on the three voicing attributes were noted by our 
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listeners using the CAPE-VM.  Thus, more research is indicated to determine if specific 
perceptual attributes can contribute to charting disease progression and treatment outcomes. 
 Findings from categorical listening tasks revealed that listeners had varying levels of 
accuracy when asked to indicate what vowel they perceived, if the voice was disordered or non-
disordered, and gender of the speaker.  It was hypothesized that listeners would also have a more 
difficult time determining which vowel was perceived when listening to FA individuals in 
comparison to NV individuals, but this was not the case.  For the vowel /a/, listeners perceived, 
on average, which vowel was heard in the NV samples more correctly than in the FA voice 
samples.  For the vowels /i/ and /o/, the opposite was true; listeners perceived which vowel was 
heard more accurately in the FA voice samples.  Thus, it would appear that spectral features 
leading to vowel identification were available in the 2000 ms samples. 
 It was hypothesized that listeners would be able to determine which voice samples were 
recorded from voices that were disordered versus non-disordered, yet this was the category with 
the least number of matches with actual information out of the three categorical perceptual tasks.  
Listeners were slightly more accurate in identifying speakers who were neurologically normal 
than those in the FA group, which suggests that overall judgments of severity might have been 
more difficult because the task involves a summation of perception, rather than focusing on one 
or more distinct vocal attributes.  Further, perhaps those in the FA group had voices that were 
relatively unaffected as of yet by the disease process.  
 Out of the three categorical tasks, listeners were most accurate in identifying correct 
gender.  Results slightly favored more accurate gender identification in the normal voice samples 
as compared to the FA voice samples.  This finding could be related to the younger overall age 
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of those in the FA group who might have had fundamental frequencies within an ambiguous 
range, somewhere between adult male and female averages. 
 Lastly, the three voice features of roughness, breathiness, and strain were all significantly 
correlated.  Thus, as one attribute was perceived as increasing in level, the others were also 
found to increase.   
 
Conclusions 
 
 The requirements of individuals to prolong vowels demand breath support, neural control 
of muscles, and a quality of voice that does not interfere with listener identification.  Individuals 
with Friedreich’s ataxia, whose breath support, neural control, and quality of voice (among other 
characteristics) are affected, are a unique population to study.  The present study was designed in 
an attempt to determine if perceptual analyses were useful in comparing those with Friedreich 
ataxia voices to individuals who had normal voices (i.e., neurologically normal). 
 As expected, during perceptual analysis with a modified CAPE-V form (CAPE-VM), 
listeners rated the Friedreich’s ataxia voice samples as more deviant from the norm when 
compared to normal voice samples on the three voice attributes studied: roughness, breathiness, 
and strain.  Based on a review of the literature, the use of the CAPE-V in modified form was the 
first time it has been used for perceptual ratings in studies of those with FA.  On the form, 
percepts were recorded on a 100 millimeter line on which listeners placed a mark on the line to 
indicate their rating of deviance from normal.  This visual analog scaling afforded advantages 
over Liekert-like perceptual scaling methods in that slight gradations in deviance could be noted, 
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rather than forcing decisions into discrete points (e.g., 1-7 scale) or categories (e.g., disordered or 
non-disordered).  It would appear that the CAPE-VM scaling system was sensitive to the subtle 
differences in voice attributes between the groups; whereas, the more holistic categorical choice 
of disordered versus non-disordered was not as sensitive to the mild voicing differences.  Based 
on our findings, the CAPE-VM is suggested as a perceptual tool that may be of benefit in 
monitoring changes over time in the speech/voice systems of those who have FA.  More research 
is necessary to determine the applicability of the CAPE-V, CAPE-VM or other modifications 
thereof, in longitudinal studies that incorporate acoustic and perceptual analyses.  The ability of 
tools/assessments to detect minimal deterioration in speech and/or voice motor performance over 
time in progressive diseases is critical to validation of treatments. 
  
Limitations 
 
 This study would have benefited from a more exact age matching of the individuals in the 
FA and NV groups.  In addition, the listeners who analyzed the voice samples should have each 
listened to a different randomized order, rather than all ten listeners listening to the voice 
samples in one randomized order in order to rule out listener fatigue.  While listening to the 
voice samples from France, an echo was sometimes heard, whereas the voice samples from UCF 
did not contain the echo.  Although the nyquist theory states that different sampling rates used 
throughout this study between the two groups (NV/FA) should not have caused any issues, this 
could be considered a limitation.  Future studies would benefit from voice or speech recordings 
collected in a sound treated environment/booth. 
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Future Studies 
 
Findings from the current study provide important information that may lead to further 
investigation of perceptual characteristics of individuals with FA.  To determine if an 
individual’s voice deviates from the norm, more extensive research should be conducted on age-
matched individuals with FA, as well as normal controls, with use of listener groups.  The FA 
and NV individuals should produce sentences as well as prolong vowels, for perceptual analysis, 
to verify if one measurement is more reliable than the other.  With use of prolonged vowels as 
well as production of sentences, clinicians are able to analyze speech rate.  Clinicians are more 
sensitive to slowness of speech than to any other feature of spoken language during dysarthria 
evaluation (Brendel, 2013).  Each listener should be analyzing the voice samples in a randomized 
order, with listeners having their own randomized order to analyze.  Acoustic analysis, with use 
of perceptual analysis, should also be conducted in order to correlate the findings.  Training 
clinicians to use the CAPE-V as one source of differential diagnosis would be of benefit to the 
clinician, and to clients with voice disorders.  Perceptual measures are a useful aid in the therapy 
process, from baseline to follow-up.  When used appropriately, perceptual measures can assist in 
determining if an individual’s voice is deviant, how the deviant quality of voice affects the 
client’s life, determining what treatment conditions should be applied, as well as documenting 
therapy progress. 
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APPENDIX A: INFORMED CONSENT (VOICE SAMPLES) 
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Acoustic Analysis in Normal, Young, College Students 
Informed Consent 
 
Principal Investigator(s):   Tara Varsallone  
 
Sub-Investigator(s):    Kaylea Hardin        
 
Faculty Supervisor:  Jack Ryalls, PhD    
 
Investigational Site(s):  University of Central Florida, Department of Communication 
Sciences and Disorders University of Central Florida, Communication Disorders Clinic 
 
Introduction:Researchers at the University of Central Florida (UCF) study many topics.  To do 
this we need the help of people who agree to take part in a research study.  You are being invited 
to take part in a research study which will include about 20 people at UCF. You have been asked 
to take part in this research study because you are a normal speaking UCF speaking. You must 
be 18 years of age or older to be included in the research study.   
 
The person doing this research is Tara Varsallone, Masters Student in the Communication 
Sciences & Disorders graduate program. Because the researcher is a graduate student, sheis 
being guided by Dr. Jack Ryalls, a UCF faculty supervisor in Communication Sciences & 
Disorders. Kaylea Hardin is a Graduate UCF student, who is also participating in this study as 
part of the research team.  
 
What you should know about a research study: 
• Someone will explain this research study to you.  
• A research study is something you volunteer for.  
• Whether or not you take part is up to you. 
• You should take part in this study only because you want to.   
• You can choose not to take part in the research study.  
• You can agree to take part now and later change your mind.  
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• Whatever you decide it will not be held against you. 
• Feel free to ask all the questions you want before you decide. 
 
Purpose of the research study:  The purpose of this study is to establish normative voice 
measures of speech from young, college students at UCF. Multidimensional Voice Profile 
(MDVP) quickly and easily provides a revealing snapshot of voice quality. Since its 
introduction, MDVP has garnered numerous references in peer-reviewed professional journals 
establishing its reliability, value of multiple parameters, and efficacy. There is an extensive 
database of normal adult speakers available for the MDVP provided by Kay Elemetrics, but this 
data is not broken down by age of speaker. We would like to obtain a database and voice 
parameters for young, normal, healthy, college age students.  
 
What you will be asked to do in the study: Participants will be asked to say various vowel 
sounds into a microphone on a digital recorder. Speakers will be recorded in a quiet 
environment.  
 
Location:  University of Central Florida, Department of Communication Sciences & Disorders 
and University of Central Florida, Communication Disorders Clinic.  
 
Time required:  We expect that you will be in this research study for 1 session of no more than 
15 minutes.   
Audio or video taping:  You will be audio taped during this study.  If you do not want to be 
audio taped, you will not be able to participate in the study. Discuss this with the researcher or a 
research team member.  If you are audio taped, the tape will be kept in a locked, safe place.  The 
tape will be erased or destroyed after completion of the study. 
 
Risks:  There are no reasonably foreseeable risks or discomforts involved in taking part in this 
study.  
 
Benefits:  There are no expected benefits to you for taking part in this study.  
 
Compensation or payment:There is no compensation or other payment to you for taking part in this 
study.  
 
Confidentiality:  We will limit your personal data collected in this study to people who have a 
need to review this information. We cannot promise complete secrecy. 
 
Study contact for questions about the study or to report a problem:If you have questions, 
concerns, or complaints, talk to Tara Varsallone, Graduate Student, Communication Sciences & 
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Disorders Program, College of Health and Public Affairs, (407) 823-4798 or Dr. Jack Ryalls, 
Faculty Supervisor, Department of Communication Sciences & Disorders at (407) 823-4798 or 
by email at ryalls@ucf.edu.  
 
IRB contact about your rights in the study or to report a complaint:    Research at the 
University of Central Florida involving human participants is carried out under the oversight of 
the Institutional Review Board (UCF IRB). This research has been reviewed and approved by the 
IRB. For information about the rights of people who take part in research, please contact: 
Institutional Review Board, University of Central Florida, Office of Research & 
Commercialization, 12201 Research Parkway, Suite 501, Orlando, FL32826-3246 or by 
telephone at (407) 823-2901. You may also talk to them for any of the following:  
• Your questions, concerns, or complaints are not being answered by the research team. 
• You cannot reach the research team. 
• You want to talk to someone besides the research team. 
 
Your signature below indicates your permission to take part in this research. 
 
DO NOT SIGN THIS FORM AFTER THE IRB EXPIRATION DATE 
BELOW 
  
Name of participant 
   
Signature of participant   Date 
   
Signature of person obtaining consent  Date 
  
Printed name of person obtaining consent 
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APPENDIX B: UCF IRB APPROVAL FORM 
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APPENDIX C: INFORMED CONSENT (LISTENERS) 
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Perceptual Analysis in Normal, Young, College Students 
Informed Consent  
 
 
Principal Investigator(s):   Tara Varsallone 
 
Co-Investigator(s):    Kaylea Hardin  
 
Research Associate(s):            Bari Hoffman Ruddy, PhD      
            
Faculty Supervisor:  John Ryalls, PhD  
      
 
Investigational Site(s):  University of Central Florida, Department of Communication 
Sciences       & Disorders 
University of Central Florida Communication Sciences and 
Disorders  Clinic 
 
Introduction:  Researchers at the University of Central Florida (UCF) study many topics.  To do 
this we need the help of people who agree to take part in a research study.  You are being invited 
to take part in a research study which will include one group of about 10 people at UCF.  You 
have been asked to take part in this research study because you are a normal hearing UCF 
student who has taken Voice Disorders at the Graduate level. You must be 18 years of age or 
older to be included in the research study.   
 
The person doing this research is Tara Varsallone, Masters Student in the Communication 
Sciences & Disorders graduate program.  Because the researcher is a graduate student, she is 
being guided by Dr.John Ryalls, a UCF faculty supervisor in Communication Sciences & 
Disorders.  Kaylea Hardin is a Graduate UCF student, who is also participating in this study as 
part of the research team. 
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What you should know about a research study: 
• Someone will explain this research study to you.  
• A research study is something you volunteer for.  
• Whether or not you take part is up to you. 
• You should take part in this study only because you want to.   
• You can choose not to take part in the research study.  
• You can agree to take part now and later change your mind.  
• Whatever you decide it will not be held against you. 
• Feel free to ask all the questions you want before you decide. 
 
Purpose of the research study:  The purpose of this study is to establish normative voice 
measures of speech from young, college students at UCF. Consensus Auditory-Perceptual 
Evaluation of Voice (CAPE-V) provides a perceptual rating of voice quality.  Since its 
introduction, CAPE-V has garnered numerous references in peer-reviewed professional journals 
establishing its reliability, value of multiple ratings, and parameters.  Perceptual ratings are the 
Golden Standard in the field of Communication Sciences and Disorders.  The CAPE-V provides 
a structured rating scale for these measures to be analyzed.  We would like to obtain a data base 
and voice ratings for young, normal, healthy college-aged students. 
 
What you will be asked to do in the study: Participants will be asked to listen to voices and 
answer a specific question questions created by the researchers in regards to voice samples.   
 
Location:  University of Central Florida, Department of Communication Sciences & Disorders 
and University of Central Florida, Communication Disorders Clinic. 
 
Time required:  We expect that you will be in this research study for 1 session for 
approximately an hour.  
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Risks: There are no reasonably foreseeable risks or discomforts involved in taking part in this 
study 
 
Benefits:  Participants will be provided with pizza for their time.   
 
Compensation or payment:  There is no compensation or other payment to you for taking part in this 
study.  
 
Confidentiality: We will limit your personal data collected in this study to people who have a 
need to review this information. We cannot promise complete secrecy.  
 
   
 
Study contact for questions about the study or to report a problem: If you have questions, 
concerns, or complaints, talk to Tara Varsallone, Graduate student, Communication Sciences & 
Disorders Program, College of Health and Public Affairs, (407) 823- 4798 or Dr. John Ryalls, 
Faculty Supervisor, Department of Communication Sciences & Disorders at (407) 823- 4798 or 
by E-Mail at Ryalls@ucf.edu. 
 
IRB contact about your rights in the study or to report a complaint:    Research at the 
University of Central Florida involving human participants is carried out under the oversight of 
the Institutional Review Board (UCF IRB). This research has been reviewed and approved by the 
IRB. For information about the rights of people who take part in research, please contact: 
Institutional Review Board, University of Central Florida, Office of Research & 
Commercialization, 12201 Research Parkway, Suite 501, Orlando, FL 32826-3246 or by 
telephone at (407) 823-2901. You may also talk to them for any of the following:  
• Your questions, concerns, or complaints are not being answered by the research team. 
• You cannot reach the research team. 
• You want to talk to someone besides the research team. 
• You want to get information or provide input about this research.  
 
 
Withdrawing from the study: 
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• If you decide to leave the research, you will not be penalized but can’t take credit for 
participation (e.g. on a resume, application, etc.) If you decide to leave the study, contact 
the investigator so that the investigator can recruit another participant as soon as possible. 
The person in charge of the research study or the sponsor can remove you from the 
research study without your approval. Possible reasons for removal include failure to 
follow instructions of the research staff, not attending training session(s) (if applicable), if 
a hearing loss is acquired before participation, and/or if the person in charge decides that 
the research study is no longer in your best interest. The sponsor can also end the 
research study early. We will tell you about any new information that may affect your 
health, welfare or choice to stay in the research. 
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APPENDIX D: DEBRIEFING FORM (LISTENERS) 
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Debriefing Statement 
 
For the study entitled: 
 
“Perceptual Analysis in Normal, Young, College Students” 
   
 
Dear Participant; 
 
During this study, you were asked to listen to voice samples and rating voice quality using a modified 
CAPE-V and/or answering questions created by the researchers.  You were told that the purpose of the 
study was to collect data on the characteristics of normal and disorder voices. The actual purpose of the 
study was to collect data on these characteristics, but information was withheld about the language of the 
participants which included English and French speakers. 
 
We did not tell you everything about the purpose of the study because we wanted to minimize bias when 
identifying if the voice was normal or disordered. The disordered voices were collected from French 
speakers.    
 
You are reminded that your original consent document included the following information: Participants will 
be asked to attend a training session for one hour on the CAPE-V with Dr. Bari Hoffman Ruddy.  During 
the training session, Dr. Ruddy will provide a tutorial on the CAPE-V, and show voice samples to practice 
how to use the protocol.  On another day, the same participants who have been trained will be asked to 
listen to the various recorded voice samples and answer specific questions on a modified CAPE-V and 
questions created by the researchers about the voice samples.   
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You have the right to withdraw from this study at any time with no penalty. If you have any concerns 
about your participation or the data you provided in light of this disclosure, please discuss this with us.  
We will be happy to provide any information we can to help answer questions you have about this study. 
 
The responses in this study are de-identified and cannot be linked to you. 
 
Study contact for questions about the study or to report a problem: If you have questions, concerns, 
or complaints or think the research has hurt you: Tara Varsallone or Kaylea Hardin, Graduate Student, 
Communication Sciences and Disorders, College of Health Public Affairs, (407) 823-4798 or Dr. Jack 
Ryalls, Faculty Supervisor, Department of Communication Sciences and Disorders at (407) 823-4798.  
 
IRB contact about your rights in the study or to report a complaint:    Research at 
the University of Central Florida involving human participants is carried out under the 
oversight of the Institutional Review Board (UCF IRB). This research has been reviewed 
and approved by the IRB. For information about the rights of people who take part in 
research, please contact: Institutional Review Board, University of Central Florida, 
Office of Research & Commercialization, 12201 Research Parkway, Suite 501, Orlando, 
FL 32826-3246 or by telephone at (407) 823-2901. 
 
If you have experienced distress as a result of your participation in this study, a referral list of mental 
health providers is attached to this document for your use.6 (Please remember that any cost in seeking 
medical assistance is at your own expense.) 
 
Please again accept our appreciation for your participation in this study. 
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APPENDIX E: LISTENER INFORMATION 
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Listener    Age    Gender 
Listener 1     30    Female 
Listener 2       23    Female 
Listener 3    22    Female 
Listener 4     22    Female 
Listener 5     23    Female 
Listener 6     22    Female 
Listener 7     22    Female 
Listener 8       23    Female 
Listener 9    23     Female 
Listener 10     22                                     Female 
 
 
 
 
 
 
 
 
 
49 
 
APPENDIX F: MODIFIED CAPE-V FORM 
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Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V)-Modified 
 
 
Voice Sample #:                                                                       Date:___________ 
 
The following parameter of voice quality will be rated upon completion of the following tasks: 
• Sustained vowels, /a/ /i/ /o/ for 2 seconds duration each. 
 
Legend: C = Consistent I = Intermittent 
               MI = Mildly Deviant 
   MO = Moderately Deviant 
               SE = Severely Deviant 
         
        SCORE 
 
Roughness                        C   I   ___/100 
                                            MI            MO    SE 
 
 
Breathiness                       C   I   ___/100 
                                            MI            MO    SE   
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Strain                       C   I   ___/100 
                                            MI            MO    SE 
 
 
 
 
 
COMMENTS ABOUT RESONANCE:   NORMAL  OTHER (Provide description):_______________ 
 
____________________________________________________________________________________ 
ADDITIONAL FEATURES (for example, diplophonia, fry, falsetto, asthenia, aphonia, pitch instability, 
tremor, wet/gurgly, or other relevant terms): 
 
 
Student Code:         
   
 
Sample Code: _______________ 
 
 
Perceived Vowel: _____________ 
 
 
Circle one of the following: 
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 Disordered          or          Non-disordered 
 
 
Male        or         Female 
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APPENDIX G: LISTENER INSTRUCTIONS 
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1. Sit down at lab computer 
2. Put on the headphones 
3. Play a Youtube video and adjust the volume to what is most comfortable to you 
4.  You may not adjust the volume once you start listening to the voice samples 
5.  Start with the first voice sample and listen to them in the order provided to you 
6.  You may listen to each voice sample up to three times each 
7.  Put your responses on the Modified Cape-V form 
8.  If you have any questions, raise your hand and we will come to help 
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APPENDIX H: PERCEPTUAL MEASURES RAW DATA 
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Listener 1 
Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
fa07arM 25 13 1 n/a a Non male 
nv15orM 34 0 0 n/a u Non male 
fa20irM 0 0 0 n/a i Non male 
nv08arF 0 0 0 n/a a Non female 
fa25irF 12 0 2 hypernasal i Disordered male 
fa27irM 0 0 0 n/a i Non male 
fa13arF 2 0 11 n/a a Disordered female 
fa07orM2 17 0 0 n/a o Disordered male 
fa23arM 0 36 35 n/a ^ Disordered male 
nv06irF 0 0 0 n/a i Non female 
fa29arM 0 0 0 n/a a Non male 
fa06irF 0 21 12 n/a i Disordered female 
fa33arM 4 0 0 n/a a Non male 
fa33irM2 4 0 0 n/a i Non male 
fa33irM 0 0 0 n/a i Non male 
nv04orF 0 0 12 n/a a Disordered male 
fa29irM 26 4 0 n/a i Non male 
nv12arF 0 0 2 n/a a Non female 
nv05irF2 1 1 1 n/a i Non female 
nv03irF 0 0 0 n/a i Non female 
nv03orF 0 0 0 n/a o Non female 
fa30arM 0 0 37 n/a a Disordered male 
nv07irF 0 0 5 n/a i Disordered female 
nv20irM 0 0 1 n/a i non male 
nv05irF 0 0 3 n/a i non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
nv02arF 18 0 11 n/a a disordered Male 
fa30irM 33 24 2 n/a i disordered Male 
fa27arM 25 1 1 n/a a disordered Male 
nv18irM 1 1 1 n/a i non Male 
nv09arM 1 0 3 n/a a non Male 
fa30orM 62 0 0 n/a o disordered Male 
nv01orF 19 1 34 n/a o disordered Female 
fa11irF 4 0 20 n/a i non Male 
nv16arM 3 4 0 n/a a non Male 
nv10irM 26 4 11 n/a i non Male 
fa29orM 0 0 0 n/a u non Male 
nv02irF 0 15 26 n/a i disordered Female 
fa19irF 0 5 1 n/a i non Female 
nv14arM 1 1 12 n/a a non Male 
nv13arF 0 0 14 n/a a non Female 
fa27orM 47 0 35 n/a u disordered Male 
nv03arF 3 0 0 n/a a non Female 
nv10orM 11 0 3 n/a o non Male 
nv11irM 4 0 12 n/a i non Male 
nv14irM 24 0 12 n/a i non Male 
fa23irM 3 61 51 n/a i disordered Male 
nv04arF 3 37 53 n/a a disordered Female 
nv05orF 0 24 4 n/a a disordered Female 
nv08orF 0 17 2 n/a ^ non Female 
nv17irM 2 22 15 n/a i non Male 
fa22arM 0 13 34 n/a a non Male 
nv04irF 0 0 3 n/a i non Female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
nv17arM 15 4 39 n/a a disordered Male 
nv05arF 0 0 2 n/a a non Female 
nv20orM 4 0 3 n/a o non Male 
fa18orF 0 18 50 n/a o disordered male 
nv06arF 3 0 18 n/a a non female 
nv13irF 17 0 39 n/a i non female 
nv02orF 1 20 0 n/a o non female 
nv08orF2 2 5 0 n/a ^ non female 
fa17arM 11 55 67 n/a a disordered male 
nv06orF 1 4 0 n/a o non female 
nv08irF 3 0 15 n/a i non female 
fa33orM 16 0 44 n/a o disordered male 
fa29arM2 0 4 25 n/a a non male 
fa12irF 36 0 65 n/a i disordered female 
nv07orF 35 18 0 n/a o non female 
nv01irF 14 0 21 n/a i non female 
fa25orF 86 1 35 n/a o disordered female 
fa20orM2 75 25 37 n/a ^ disordered male 
fa11arF 15 1 37 n/a a non female 
nv09orM 4 66 53 n/a o disordered male 
fa22irM 67 11 52 n/a i disordered male 
fa20arM 0 64 0 n/a a non male 
nv11orM2 82 77 82 n/a ^ disordered male 
fa09arM 58 50 79 n/a a disordered female 
nv12orF 0 0 0 n/a o non female 
fa17irM 41 91 98 n/a i disordered male 
fa13orF 100 0 66 n/a o disordered female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
nv15orM2 59 15 77 n/a u disordered male 
fa08irF 13 0 21 n/a i disordered female 
nv14orM 0 0 0 n/a o non female 
fa10orF 4 76 0 n/a o disordered female 
fa09irM 44 20 97 n/a i disordered male 
nv20arM 0 0 0 n/a a non male 
fa07orM 0 23 13 n/a o disordered male 
nv15irM 0 0 0 n/a i non male 
fa03irF 0 23 11 n/a i non female 
fa06orF 0 0 17 n/a o disordered female 
nv19arM 45 83 68 n/a a disordered male 
fa08orF 0 12 34 n/a u disordered female 
nv16orM 41 46 38 n/a o non male 
fa07irM 4 0 0 n/a i non male 
fa03orF 23 3 0 n/a o non female 
nv17orM 69 0 23 n/a o disordered male 
fa10irF 58 39 58 n/a i non male 
nv18arM 0 0 0 n/a a non male 
fa10arF 0 38 0 n/a a non female 
fa03arF 0 0 24 n/a a non female 
nv16irM 44 0 0 n/a i non male 
fa12arF 21 0 35 n/a a non female 
nv18orM 36 0 0 n/a u non male 
fa12orF 51 3 0 n/a u disordered female 
fa06arF 0 62 38 n/a a disordered female 
nv15arM 0 0 0 n/a a non male 
fa17orM 52 0 82 n/a u disordered male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
nv19irM 23 42 0 n/a i non male 
fa19orF 47 61 0 n/a u disordered female 
fa08arF 41 0 78 n/a a disordered female 
nv13orF 0 0 0 n/a o non female 
fa18arF 13 0 40 n/a a non male 
nv19orM 0 0 0 n/a n/a non male 
fa23orM 65 41 90 n/a o disordered male 
fa09orM 100 53 97 n/a u disordered female 
nv12irF 0 0 0 n/a i non female 
fa19arF 93 0 77 n/a a disordered female 
fa23orM2 37 0 62 n/a o disordered male 
nv01arF 6 0 0 n/a a non female 
fa11orF 35 63 17 n/a ʊ disordered male 
nv11orM 65 0 0 n/a ʊ non male 
fa20orM 0 18 4 n/a ʊ disordered male 
nv03orF2 0 0 1 n/a o non female 
nv07arF 3 51 35 n/a a non female 
fa13irF 57 0 62 n/a i disordered female 
nv10arM 12 3 0 n/a a non male 
fa22orM 45 52 0 n/a u disordered male 
nv01orF2 0 64 37 n/a o disordered female 
nv11arM 0 0 3 n/a a non male 
fa18irF 34 38 91 n/a i disordered female 
nv09irM 0 0 0 n/a i non male 
fa25arF 0 0 36 n/a a non female 
fa06arF2 0 67 0 n/a a disordered female 
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Listener 2 
Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
fa07arM 0 4 2 n/a a non male 
nv15orM 3 0 0 n/a o non male 
fa20irM 1 15 22 n/a i non male 
nv08arF 0 0 0 n/a a non female 
fa25irF 0 5 5 n/a i non female 
fa27irM 27 35 42 n/a i n/a male 
fa13arF 60 76 76 n/a a disordered female 
fa07orM2 2 25 2 
slight 
tremor o n/a male 
fa23arM 10 50 53 n/a a disordered male 
nv06irF 0 0 0 n/a i non female 
fa29arM 9 20 0 n/a a non male 
fa06irF 4 26 0 n/a i non female 
fa33arM 4 0 34 n/a a non male 
fa33irM2 0 20 10 n/a i non male 
fa33irM 0 0 10 n/a i non male 
nv04orF 0 0 2 high pitch a non female 
fa29irM 12 1 42 n/a i n/a male 
nv12arF 25 1 36 n/a a n/a female 
nv05irF2 10 0 25 n/a i non female 
nv03irF 0 0 5 n/a i non female 
nv03orF 5 0 5 n/a o n/a female 
fa30arM 0 0 34 
small 
tremor a disordered male 
nv07irF 3 20 47 n/a i disordered female 
nv20irM 0 0 0 n/a i non male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
nv05irF 0 0 42 n/a i n/a female 
nv02arF 12 0 65 n/a a disordered female 
fa30irM 35 21 39 n/a i disordered male 
fa27arM 25 0 17 n/a a non male 
nv18irM 40 2 53 n/a i disordered male 
nv09arM 24 4 33 n/a a disordered male 
fa30orM 15 36 39 low pitch o disordered male 
nv01orF 55 44 61 n/a o disordered female 
fa11irF 46 35 59 n/a i disordered male 
nv16arM 45 18 35 n/a a disordered male 
nv10irM 34 16 23 n/a i disordered male 
fa29orM 11 0 15 n/a o disordered male 
nv02irF 35 10 63 n/a i disordered female 
fa19irF 24 0 35 n/a i disordered female 
nv14arM 15 11 2 n/a a non male 
nv13arF 35 44 33 n/a a disordered female 
fa27orM 66 0 23 Tremor o disordered male 
nv03arF 35 0 53 n/a a disordered female 
nv10orM 24 0 10 n/a o disordered male 
nv11irM 56 3 53 n/a i disordered male 
nv14irM 12 3 15 Shaky i n/a male 
fa23irM 58 51 66 n/a i disordered male 
nv04arF 66 23 68 n/a a disordered female 
nv05orF 37 1 63 n/a o disordered female 
nv08orF 0 0 0 n/a a non female 
nv17irM 25 0 11 n/a i disordered male 
fa22arM 48 1 23 n/a a disordered male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
nv04irF 2 0 12 n/a i non female 
nv17arM 50 41 48 n/a a disordered male 
nv05arF 13 0 0 Shaky a non female 
nv20orM 5 0 4 n/a o non male 
fa18orF 62 0 64 n/a o disordered male 
nv06arF 25 5 28 n/a a disordered male 
nv13irF 24 0 76 n/a i disordered female 
nv02orF 38 0 61 n/a o disordered female 
nv08orF2 0 0 2 n/a a non female 
fa17arM 26 0 24 n/a a disordered male 
nv06orF 0 0 0 n/a o non female 
nv08irF 3 1 14 n/a i disordered female 
fa33orM 0 0 0 low pitch o non male 
fa29arM2 10 0 0 n/a a non male 
fa12irF 45 0 75 n/a i n/a female 
nv07orF 48 0 10 
deep 
voice o non female 
nv01irF 0 0 15 n/a i non female 
fa25orF 13 0 10 n/a o non female 
fa20orM2 39 0 16 n/a o non male 
fa11arF 15 0 0 n/a o non male 
nv09orM 19 0 0 n/a a non female 
fa22irM 49 0 64 n/a i disordered male 
fa20arM 44 12 33 n/a a disordered male 
nv11orM2 17 5 42 Tremor o disordered male 
fa09arM 26 0 55 
pitch 
instability a disordered female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
nv12orF 4 0 2 n/a o non female 
fa17irM 22 10 60 Tremor i disordered male 
fa13orF 11 16 75 n/a o disordered female 
nv15orM2 45 0 26 n/a o non male 
fa08irF 3 0 11 n/a i non female 
nv14orM 0 0 0 n/a o non male 
fa10orF 10 0 51 n/a o disordered female 
fa09irM 0 0 73 n/a i disordered female 
nv20arM 0 0 4 n/a a non male 
fa07orM 11 0 18 n/a o non male 
nv15irM 4 0 19 n/a i non male 
fa03irF 16 0 42 Loud i n/a female 
fa06orF 58 11 80 n/a o disordered male 
nv19arM 13 36 52 n/a a disordered male 
fa08orF 53 0 51 n/a o disordered female 
nv16orM 22 0 12 n/a o non male 
fa07irM 9 0 19 n/a i non male 
fa03orF 51 0 20 n/a o disordered female 
nv17orM 39 0 67 n/a o disordered male 
fa10irF 35 0 25 n/a i disordered female 
nv18arM 4 4 0 n/a a non male 
fa10arF 10 0 44 n/a a disordered female 
fa03arF 52 0 46 n/a a disordered female 
nv16irM 2 0 4 n/a i non male 
fa12arF 3 0 16 n/a a non female 
nv18orM 5 0 8 n/a o non male 
fa12orF 5 0 0 n/a o non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
fa06arF 14 0 13 n/a a non female 
nv15arM 0 0 0 n/a a non male 
fa17orM 3 37 76 Tremor o disordered male 
nv19irM 0 0 0 n/a i non male 
fa19orF 37 0 51 Tremor o disordered female 
fa08arF 11 0 59 Tremor a disordered female 
nv13orF 10 1 39 n/a o disordered female 
fa18arF 22 0 24 n/a a non male 
nv19orM 61 0 57 n/a a disordered male 
fa23orM 11 0 9 n/a o non male 
fa09orM 78 0 93 n/a o disordered female 
nv12irF 0 0 14 n/a i non female 
fa19arF 48 0 73 n/a a disordered female 
fa23orM2 23 0 68 n/a o disordered male 
nv01arF 2 0 4 n/a a non female 
fa11orF 40 0 24 n/a o non male 
nv11orM 45 0 64 Tremor o disordered male 
fa20orM 13 17 21 n/a o disordered male 
nv03orF2 16 0 21 n/a o non female 
nv07arF 44 0 55 n/a a disordered female 
fa13irF 23 0 26 n/a i non female 
nv10arM 0 0 6 n/a a non male 
fa22orM 6 0 7 n/a o non male 
nv01orF2 39 3 60 n/a o disordered female 
nv11arM 7 2 36 Tremor a n/a male 
fa18irF 15 0 5 n/a i non female 
nv09irM 0 0 0 n/a i non male 
66 
 
Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
fa25arF 16 0 55 n/a a disordered female 
fa06arF2 6 37 46 n/a a disordered female 
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Listener 3 
Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
fa07arM 0 0 0 n/a a non male 
nv15orM 0 0 0 n/a o non male 
fa20irM 0 0 5 n/a i n/a male 
nv08arF 0 0 0 n/a a n/a female 
fa25irF 0 0 25 Nasal i n/a female 
fa27irM 19 0 6 
pitch 
slightly 
unstable i non male 
fa13arF 4 5 4 n/a a disordered female 
fa07orM2 3 2 0 n/a o non male 
fa23arM 0 6 25 
pitch 
instability a disordered male 
nv06irF 0 0 0 n/a i non female 
fa29arM 5 0 0 n/a a non male 
fa06irF 0 5 31 n/a i disordered female 
fa33arM 26 0 25 n/a a non male 
fa33irM2 10 0 28 n/a i non male 
fa33irM 4 1 18 n/a i non male 
nv04orF 0 5 2 n/a a non female 
fa29irM 44 26 56 n/a i disordered male 
nv12arF 0 0 0 n/a a non female 
nv05irF2 0 0 1 n/a i non female 
nv03irF 0 0 0 n/a i non female 
nv03orF 0 0 5 n/a o non female 
fa30arM 27 20 30 n/a a disordered male 
nv07irF 0 5 0 n/a i non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
nv20irM 0 0 0 n/a i non female 
nv05irF 0 0 3 n/a i non female 
nv02arF 0 13 4 n/a a disordered female 
fa30irM 27 28 33 n/a i disordered male 
fa27arM 18 4 26 n/a a disordered male 
nv18irM 0 15 13 n/a i non male 
nv09arM 0 0 0 n/a a non male 
fa30orM 27 31 30 n/a o disordered male 
nv01orF 0 35 20 n/a o disordered female 
fa11irF 0 13 43 
pitch 
instability i disordered male 
nv16arM 20 0 44 n/a a disordered male 
nv10irM 30 0 37 wet/gurgly i disordered male 
fa29orM 22 5 30 n/a o disordered male 
nv02irF 0 4 8 
pitch 
instability i non female 
fa19irF 0 4 36 
pitch 
instability i non female 
nv14arM 0 0 2 n/a a non male 
nv13arF 0 0 3 n/a a non female 
fa27orM 23 14 29 Tremor o disordered male 
nv03arF 0 0 1 n/a a non female 
nv10orM 0 3 3 n/a o non male 
nv11irM 9 0 22 
pitch 
instability i non male 
nv14irM 3 0 5 n/a i non male 
fa23irM 24 30 0 Nasal i disordered male 
nv04arF 0 14 14 n/a a non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
nv05orF 0 0 0 n/a o non female 
nv08orF 0 0 0 n/a a non female 
nv17irM 0 0 27 n/a i non male 
fa22arM 4 23 23 
pitch 
instability a disordered male 
nv04irF 0 0 0 n/a i non female 
nv17arM 28 14 26 Aphonia a disordered male 
nv05arF 0 0 0 n/a a non female 
nv20orM 0 0 0 n/a o non male 
fa18orF 7 5 0 n/a o non female 
nv06arF 0 4 12 n/a a non female 
nv13irF 0 0 0 n/a i non female 
nv02orF 0 28 25 n/a o disordered female 
nv08orF2 0 0 0 n/a a non female 
fa17arM 8 5 4 low pitch o non female 
nv06orF n/a n/a n/a n/a n/a n/a n/a 
nv08irF 0 0 0 n/a i non female 
fa33orM 22 22 30 
pitch 
instability o disordered male 
fa29arM2 35 17 29 n/a a disordered male 
fa12irF 15 40 51 n/a i disordered female 
nv07orF 33 0 29 n/a a disordered male 
nv01irF 0 0 7 Nasal i non female 
fa25orF 11 0 20 n/a o disordered female 
fa20orM2 22 3 33 Tremor o disordered male 
fa11arF 0 0 0 n/a a non female 
nv09orM 0 0 5 n/a o non male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
fa22irM 0 12 38 n/a i disordered male 
fa20arM 17 5 34 n/a a disordered male 
nv11orM2 25 0 32 n/a i disordered male 
fa09arM 12 36 49 
pitch 
instability, 
tremor a disordered female 
nv12orF 2 17 27 n/a o disordered female 
fa17irM 64 34 71 n/a i disordered male 
fa13orF 22 33 48 n/a o disordered female 
nv15orM2 0 3 11 n/a o non male 
fa08irF 2 23 32 n/a i disordered female 
nv14orM 0 0 0 n/a o non male 
fa10orF 12 21 34 
pitch 
instability o disordered female 
fa09irM 1 47 65 Aphonia i disordered female 
nv20arM 0 0 4 n/a a non male 
fa07orM 34 24 34 n/a o disordered male 
nv15irM 2 32 35 Nasal i disordered male 
fa03irF 0 13 13 n/a i non female 
fa06orF 0 19 35 n/a o disordered female 
nv19arM 33 15 31 
pitch 
instability, 
tremor a disordered male 
fa08orF 16 0 34 
pitch 
instability o disordered female 
nv16orM 50 16 47 n/a o disordered male 
fa07irM 13 13 14 n/a i non male 
fa03orF 4 20 24 pitch inst o disordered female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
nv17orM 59 17 62 Fry o disordered male 
fa10irF 0 13 13 n/a i non female 
nv18arM 3 0 16 n/a a non male 
fa10arF 0 0 18 
pitch 
instability a disordered female 
fa03arF 12 14 25 
pitch 
instability a disordered female 
nv16irM 13 0 20 Fry i non male 
fa12arF 13 21 16 n/a a disordered female 
nv18orM 12 0 23 n/a o non male 
fa12orF 0 36 36 n/a o disordered female 
fa06arF 14 49 36 n/a a disordered female 
nv15arM 0 0 0 n/a a non male 
fa17orM 23 38 62 Tremor o disordered male 
nv19irM 0 0 13 n/a i non male 
fa19orF 0 0 34 n/a o disordered female 
fa08arF 15 23 37 
pitch 
instability a disordered female 
nv13orF 0 17 32 n/a o disordered female 
fa18arF 0 40 26 Tremor a disordered female 
nv19orM 0 0 0 n/a a non male 
fa23orM 23 1 21 
pitch 
instability o disordered male 
fa09orM 36 36 34 n/a o disordered female 
nv12irF 0 0 0 n/a i non female 
fa19arF 0 20 39 
pitch 
instability a disordered female 
fa23orM2 17 18 35 pitch inst o disordered male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
nv01arF 0 3 0 n/a a non female 
fa11orF 40 20 39 low pitch o disordered female 
nv11orM 53 21 39 n/a o disordered male 
fa20orM 25 0 41 
pitch 
instability o disordered male 
nv03orF2 0 0 0 n/a o non female 
nv07arF 0 0 4 n/a a non female 
fa13irF 25 25 40 Nasal i disordered female 
nv10arM 0 0 0 n/a a non male 
fa22orM 13 15 13 n/a o non male 
nv01orF2 14 25 25 n/a o disordered female 
nv11arM 0 0 39 
pitch 
instability a disordered male 
fa18irF 0 0 0 low pitch i non female 
nv09irM 0 0 0 n/a i non male 
fa25arF 15 17 37 n/a a disordered female 
fa06arF2 0 45 19 n/a a disordered female 
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Listener 4 
Participant Roughness Breathiness Strain Other 
Perceived 
vowel IPA 
Disordered 
or Non- Gender 
fa07arM 0 60 0 n/a a disordered male 
nv15orM 0 40 0 n/a o disordered male 
fa20irM 19 0 18 n/a i disordered male 
nv08arF 0 0 0 n/a a non female 
fa25irF 0 0 17 n/a i non female 
fa27irM 0 0 0 n/a i non male 
fa13arF 0 19 0 n/a a non female 
fa07orM2 48 0 0 n/a o disordered male 
fa23arM 0 12 12 Asthenia a disordered male 
nv06irF 0 0 0 n/a i non female 
fa29arM 80 0 0 n/a a non male 
fa06irF 0 0 9 n/a i non female 
fa33arM 38 0 0 n/a a disordered male 
fa33irM2 0 0 0 n/a i non male 
fa33irM 0 0 0 n/a i non male 
nv04orF 0 0 0 n/a a non female 
fa29irM 0 0 75 n/a i disordered male 
nv12arF 0 0 0 n/a a non female 
nv05irF2 0 0 0 n/a i non female 
nv03irF 0 0 0 n/a i non female 
nv03orF 0 0 0 n/a o non male 
fa30arM 0 43 18 n/a a disordered male 
nv07irF 0 14 0 n/a i non female 
nv20irM 0 0 0 n/a e non male 
nv05irF 0 0 0 n/a e non female 
nv02arF 18 0 82 n/a a disordered female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa30irM 20 16 46 n/a a disordered male 
fa27arM 0 0 0 n/a a non male 
nv18irM 22 21 0 n/a i non male 
nv09arM 0 0 0 n/a a non male 
fa30orM 0 72 82 n/a o disordered male 
nv01orF 0 55 40 n/a o disordered female 
fa11irF 48 0 85 n/a i disordered male 
nv16arM 0 20 0 n/a a non male 
nv10irM 0 21 0 n/a i non male 
fa29orM 0 0 0 n/a i non male 
nv02irF 0 40 0 n/a i disordered female 
fa19irF 23 0 56 n/a i disordered female 
nv14arM 8 0 0 n/a a non male 
nv13arF 0 0 0 n/a a non female 
fa27orM 48 53 0 n/a o disordered male 
nv03arF 0 0 0 n/a a non female 
nv10orM 39 15 45 n/a o disordered male 
nv11irM 0 0 0 n/a E non male 
nv14irM 0 20 0 n/a e non male 
fa23irM 42 0 23 n/a E disordered male 
nv04arF 0 0 0 n/a a b female 
nv05orF 0 0 0 n/a o non female 
nv08orF 0 0 0 n/a o non female 
nv17irM 0 21 0 n/a i non male 
fa22arM 0 0 0 n/a A non male 
nv04irF 0 0 0 n/a E non female 
nv17arM 20 25 46 n/a a disordered male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv05arF 0 0 0 n/a a non female 
nv20orM 0 0 0 n/a o non male 
fa18orF 0 0 0 n/a o non male 
nv06arF 0 0 22 n/a a non female 
nv13irF 0 0 0 n/a E non female 
nv02orF 0 22 20 n/a o disordered female 
nv08orF2 0 0 0 n/a o non female 
fa17arM 0 46 0 n/a a non male 
nv06orF 0 0 0 n/a o non female 
nv08irF 0 0 0 n/a E non female 
fa33orM 42 0 0 n/a o disordered male 
fa29arM2 0 0 0 n/a a non male 
fa12irF 0 0 52 n/a E disordered female 
nv07orF 0 0 0 n/a o non female 
nv01irF 0 0 35 n/a E non female 
fa25orF 0 15 38 n/a o non female 
fa20orM2 0 35 36 n/a o non male 
fa11arF 0 0 0 n/a a non male 
nv09orM 0 0 0 n/a o non male 
fa22irM 0 14 0 n/a E non male 
fa20arM 0 22 0 n/a a non male 
nv11orM2 39 40 21 n/a o disordered male 
fa09arM 20 0 55 n/a a disordered female 
nv12orF 0 0 0 n/a a non female 
fa17irM 44 17 87 n/a I disordered male 
fa13orF 0 41 47 n/a o disordered male 
nv15orM2 0 23 0 n/a o non male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa08irF 0 0 25 n/a E non female 
nv14orM 0 0 0 n/a o non male 
fa10orF 0 24 78 n/a o disordered female 
fa09irM 0 20 61 n/a E disordered female 
nv20arM 0 0 0 n/a a non male 
fa07orM 0 0 18 n/a o non male 
nv15irM 0 0 0 n/a E non male 
fa03irF 0 0 20 n/a E non female 
fa06orF 0 23 0 n/a o non female 
nv19arM 0 25 20 n/a a disordered male 
fa08orF 0 0 37 n/a o non female 
nv16orM 60 0 0 n/a o non male 
fa07irM 0 0 0 n/a E non male 
fa03orF 0 0 62 n/a o disordered female 
nv17orM 81 0 47 n/a o disordered male 
fa10irF 0 0 33 n/a E disordered male 
nv18arM 0 0 24 n/a a disordered male 
fa10arF 29 0 42 n/a o disordered female 
fa03arF 40 0 42 n/a a disordered female 
nv16irM 0 0 0 n/a e non male 
fa12arF 0 13 0 n/a a non female 
nv18orM 0 0 0 n/a o non male 
fa12orF 10 0 24 n/a o disordered female 
fa06arF 0 0 24 n/a a non female 
nv15arM 0 0 0 n/a a non male 
fa17orM 48 60 78 n/a o disordered male 
nv19irM 0 0 0 n/a E non male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa19orF 0 0 19 n/a o non female 
fa08arF 0 0 45 n/a a disordered male 
nv13orF 0 0 19 n/a o non female 
fa18arF 0 24 55 n/a a disordered male 
nv19orM 0 0 0 n/a o non male 
fa23orM 0 46 45 n/a o disordered male 
fa09orM 22 0 86 n/a o disordered female 
nv12irF 0 0 0 n/a E non female 
fa19arF 0 13 53 n/a a disordered female 
fa23orM2 0 21 0 n/a o non male 
nv01arF 0 0 0 n/a a non female 
fa11orF 0 29 29 n/a o disordered male 
nv11orM 22 38 35 n/a o disordered male 
fa20orM 0 0 21 n/a o non male 
nv03orF2 0 0 0 n/a o non female 
nv07arF 0 24 0 n/a a non female 
fa13irF 25 0 88 n/a E disordered female 
nv10arM 0 0 0 n/a a non male 
fa22orM 0 0 0 n/a o non male 
nv01orF2 0 0 35 n/a o disordered female 
nv11arM 42 0 47 n/a a disordered male 
fa18irF 0 0 40 n/a E disordered male 
nv09irM 0 0 0 n/a E non male 
fa25arF 0 0 39 n/a a disordered female 
fa06arF2 0 0 0 n/a a non female 
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Listener 5 
Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
fa07arM 0 5 0 n/a a non male 
nv15orM 3 3 0 n/a o non male 
fa20irM 2 0 0 n/a i non male 
nv08arF 0 0 0 n/a a non female 
fa25irF 0 0 4 n/a i non female 
fa27irM 14 1 1 n/a i non male 
fa13arF 25 15 19 n/a a disordered female 
fa07orM2 0 19 3 n/a o disordered male 
fa23arM 19 21 1 n/a a disordered male 
nv06irF 0 0 0 n/a i non female 
fa29arM 5 35 0 n/a i disordered female 
fa06irF 12 26 0 n/a a disordered male 
fa33arM 26 11 0 n/a a disordered male 
fa33irM2 24 0 0 n/a i disordered male 
fa33irM 26 0 0 n/a i disordered male 
nv04orF 0 0 0 n/a a non female 
fa29irM 5 5 0 n/a i non male 
nv12arF 0 5 0 n/a a non female 
nv05irF2 0 0 5 n/a i non female 
nv03irF 0 0 0 n/a i non female 
nv03orF 0 5 0 n/a a non male 
fa30arM 0 5 0 n/a o non female 
nv07irF 5 11 0 n/a i non female 
nv20irM 0 0 0 n/a i non male 
nv05irF 0 5 1 n/a i non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv02arF 0 0 25 n/a a disordered female 
fa30irM 5 5 0 n/a i non male 
fa27arM 11 0 0 n/a a non male 
nv18irM 13 19 0 Shaky i disordered male 
nv09arM 2 5 0 n/a a non male 
fa30orM 0 21 9 Weak o disordered male 
nv01orF 0 12 11 n/a o non female 
fa11irF 0 14 13 n/a i disordered male 
nv16arM 17 33 0 n/a a disordered male 
nv10irM 5 22 0 n/a i disordered male 
fa29orM 3 10 0 n/a o non male 
nv02irF 4 20 20 Shaky i disordered female 
fa19irF 5 5 4 n/a i non female 
nv14arM 5 14 0 n/a a non male 
nv13arF 0 0 0 n/a a non female 
fa27orM 0 0 0 n/a o non male 
nv03arF 0 1 1 n/a a non female 
nv10orM 13 27 0 n/a o disordered male 
nv11irM 3 20 0 Shaky i disordered male 
nv14irM 5 4 0 n/a i non male 
fa23irM 18 19 19 n/a i disordered male 
nv04arF 0 13 12 n/a a non female 
nv05orF 0 18 19 n/a o non female 
nv08orF 0 2 2 n/a a non female 
nv17irM 13 12 0 Shaky i non male 
fa22arM 13 14 4 n/a a non male 
nv04irF 4 7 0 n/a i non female 
80 
 
Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv17arM 33 21 4 n/a a disordered male 
nv05arF 0 0 0 n/a a non female 
nv20orM 0 0 0 n/a o non male 
fa18orF 5 19 2 n/a o disordered female 
nv06arF 4 12 3 n/a a disordered female 
nv13irF 0 10 25 n/a i disordered female 
nv02orF 14 14 0 n/a o disordered female 
nv08orF2 0 0 0 n/a a non female 
fa17arM 12 12 0 n/a a disordered male 
nv06orF 0 4 0 n/a o non female 
nv08irF 0 3 13 n/a i disordered female 
fa33orM 5 4 0 n/a o non male 
fa29arM2 21 21 0 n/a a disordered male 
fa12irF 0 14 13 n/a i disordered female 
nv07orF 5 4 0 n/a o non female 
nv01irF 0 0 0 n/a i non female 
fa25orF 0 18 17 n/a o disordered female 
fa20orM2 19 20 5 n/a a disordered male 
fa11arF 22 21 11 n/a a disordered female 
nv09orM 20 19 0 n/a o disordered male 
fa22irM 5 18 0 n/a i non male 
fa20arM 21 19 0 n/a a disordered male 
nv11orM2 26 26 2 Tremor o disordered male 
fa09arM 24 24 0 n/a a disordered female 
nv12orF 5 12 0 n/a o non female 
fa17irM 20 55 0 n/a i disordered male 
fa13orF 5 26 40 n/a o disordered female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv15orM2 12 12 0 n/a o disordered male 
fa08irF 2 3 0 n/a i non female 
nv14orM 5 5 0 n/a o non male 
fa10orF 12 26 12 n/a o disordered female 
fa09irM 21 37 23 n/a i disordered female 
nv20arM 5 4 0 n/a a non male 
fa07orM 14 35 4 n/a o disordered male 
nv15irM 5 5 0 n/a i non male 
fa03irF 4 5 0 n/a i non female 
fa06orF 4 26 0 n/a o disordered female 
nv19arM 26 25 2 n/a a disordered male 
fa08orF 13 13 11 Shaky o disordered female 
nv16orM 32 23 0 n/a o disordered male 
fa07irM 26 26 0 n/a i disordered male 
fa03orF 30 30 5 n/a o disordered female 
nv17orM 49 34 3 n/a a disordered male 
fa10irF 16 26 2 n/a i disordered male 
nv18arM 25 25 0 n/a a disordered male 
fa10arF 5 19 0 n/a a non female 
fa03arF 4 3 19 n/a a disordered female 
nv16irM 23 24 0 n/a u disordered male 
fa12arF 4 25 0 n/a a disordered female 
nv18orM 26 26 0 n/a o disordered male 
fa12orF 0 26 0 n/a o disordered female 
fa06arF 27 26 3 n/a a disordered female 
nv15arM 35 35 0 n/a a disordered male 
fa17orM 25 48 0 Shaky o disordered male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv19irM 16 14 5 n/a i disordered male 
fa19orF 0 1 1 n/a o non female 
fa08arF 11 11 18 n/a a disordered female 
nv13orF 3 2 0 n/a o non female 
fa18arF 0 2 0 n/a a non male 
nv19orM 4 22 0 n/a a disordered female 
fa23orM 10 19 1 n/a o disordered male 
fa09orM 10 35 25 n/a o disordered female 
nv12irF 0 0 0 n/a i non female 
fa19arF 5 5 0 n/a a non female 
fa23orM2 5 5 0 n/a o non male 
nv01arF 0 0 0 n/a a non female 
fa11orF 5 4 0 n/a o non male 
nv11orM 5 26 0 Tremor a disordered male 
fa20orM 4 3 0 n/a a non male 
nv03orF2 5 4 0 n/a i non female 
nv07arF 6 5 0 n/a a non female 
fa13irF 0 12 13 n/a i non female 
nv10arM 4 13 0 n/a a non male 
fa22orM 0 0 0 n/a o non male 
nv01orF2 12 19 0 Shaky o disordered female 
nv11arM 13 11 0 Shaky a non male 
fa18irF 0 0 0 n/a i non female 
nv09irM 6 6 0 n/a i non male 
fa25arF 3 21 4 n/a a disordered female 
fa06arF2 24 26 1 n/a a disordered female 
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Listener 6 
Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
fa07arM 7 25 2 n/a a non male 
nv15orM 0 2 0 n/a o non male 
fa20irM 1 0 15 n/a i non male 
nv08arF 0 1 0 n/a a non female 
fa25irF 0 0 18 n/a i non female 
fa27irM 8 4 6 n/a i non male 
fa13arF 45 11 58 n/a a disordered female 
fa07orM2 26 45 25 n/a o disordered male 
fa23arM 38 38 37 n/a a disordered male 
nv06irF 0 0 0 n/a i non female 
fa29arM 9 3 1 n/a a non male 
fa06irF 0 10 4 n/a i non female 
fa33arM 32 0 35 n/a a disordered male 
fa33irM2 6 0 8 n/a i non male 
fa33irM 8 0 8 n/a i non male 
nv04orF 0 8 4 n/a a non female 
fa29irM 8 0 34 n/a i disordered male 
nv12arF 0 1 0 n/a a non male 
nv05irF2 0 1 8 n/a i non female 
nv03irF 0 1 1 n/a i non female 
nv03orF 0 1 0 n/a o non female 
fa30arM 11 30 6 n/a a disordered male 
nv07irF 0 3 1 n/a i non female 
nv20irM 0 1 0 n/a i non male 
nv05irF 1 5 3 n/a i non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv02arF 1 4 6 n/a a non male 
fa30irM 15 25 11 n/a i disordered male 
fa27arM 39 1 2 n/a a non male 
nv18irM 1 0 5 n/a i disordered male 
nv09arM 8 1 1 n/a a non male 
fa30orM 12 51 1 n/a o disordered male 
nv01orF 0 6 4 n/a o non female 
fa11irF 11 0 38 n/a i disordered male 
nv16arM 33 1 8 n/a a disordered male 
nv10irM 5 2 1 n/a i non male 
fa29orM 8 11 8 n/a o disordered male 
nv02irF 0 10 4 n/a i non female 
fa19irF 9 0 25 n/a i disordered female 
nv14arM 8 2 9 n/a a non male 
nv13arF 0 1 0 n/a a non female 
fa27orM 24 14 9 
tremor, 
poor 
vowel 
sound o disordered male 
nv03arF 0 2 1 n/a a non female 
nv10orM 8 0 1 n/a o non male 
nv11irM 8 1 4 n/a i non male 
nv14irM 8 1 5 n/a i non male 
fa23irM 24 44 21 
some 
hypernasal
ity i disordered male 
nv04arF 6 8 6 n/a a non female 
nv05orF 0 6 0 n/a o non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv08orF 0 4 0 n/a o non female 
nv17irM 3 2 6 n/a i non male 
fa22arM 24 1 50 
slight 
hyponasali
ty o disordered male 
nv04irF 0 2 1 n/a i non female 
nv17arM 20 1 10 
bit of 
pitch 
instability/
cracking 
of voice a non male 
nv05arF 0 1 0 n/a a non female 
nv20orM 4 2 1 n/a o non male 
fa18orF 1 30 2 n/a o non female 
nv06arF 0 8 0 n/a a non female 
nv13irF 0 0 8 
slight 
hyponasali
ty i non female 
nv02orF 0 4 1 n/a o non female 
nv08orF2 0 3 0 n/a o non male 
fa17arM 32 34 8 
slightly 
hyponasal, 
tremor a Disordered male 
nv06orF 0 1 0 n/a o non female 
nv08irF 0 5 3 n/a i non female 
fa33orM 38 1 1 n/a o non Male 
fa29arM2 30 2 1 n/a a non Male 
fa12irF 0 8 12 
slight 
hypernasal i non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv07orF 0 1 0 n/a o non female 
nv01irF 0 0 4 n/a i non female 
fa25orF 0 1 3 n/a o non female 
fa20orM2 30 0 25 
slightly 
hyponasal, 
slight 
pitch 
instability 
(almost 
"shaky" 
voice) o non Male 
fa11arF 4 0 24 n/a a non female 
nv09orM 0 2 0 n/a o non Male 
fa22irM 1 2 10 
slightly 
hyponasal, 
some 
pitch 
instability i non Male 
fa20arM 4 12 4 n/a a non Male 
nv11orM2 27 3 0 n/a o non Male 
fa09arM 27 35 4 
noticable 
pitch 
instability a disordered female 
nv12orF 0 3 0 n/a o non female 
fa17irM 8 66 0 
slightly 
hypernasal, 
very weak 
voice, 
maybe slight 
tremor i Disordered Male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa13orF 1 8 30 
slightly 
hyponasal, 
pitch 
instability o non female 
nv15orM2 0 1 0 n/a o non Male 
fa08irF 8 0 45 
slightly 
hypernasal i non female 
nv14orM 3 2 1 n/a o non Male 
fa10orF 3 58 1 
unstable 
voice o disordered female 
fa09irM 0 36 37 
slightly 
hypernasal i disordered female 
nv20arM 8 3 0 n/a a non Male 
fa07orM 4 28 1 
weak 
voice, 
slightly 
tremulous o disordered Male 
nv15irM 1 5 0 n/a i non Male 
fa03irF 9 3 25 n/a i non female 
fa06orF 1 11 0 n/a o non female 
nv19arM 28 2 6 
harsh fry 
at one 
point a non Male 
fa08orF 8 14 1 
pitch 
instability, 
tremor o non female 
nv16orM 37 18 1 
slight fry, 
slightly 
weak voice o n/a Male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa07irM 11 8 22 
slight 
tremor i non Male 
fa03orF 12 8 1 
pitch 
instability, 
slight 
tremor o non female 
nv17orM 43 0 26 
fry, slight 
tremor 
(shaky 
voice) o non Male 
fa10irF 3 0 36 
hyponasal, 
tremulous i disordered female 
nv18arM 35 0 27 
harsh-
sounding 
voice a non Male 
fa10arF 25 12 6 
tremulous/
unstable a disordered female 
fa03arF 34 1 26 
tremulous/
unstable a disordered female 
nv16irM 11 4 1 n/a i non Male 
fa12arF 0 21 0 n/a a non female 
nv18orM 32 0 8 slight fry o non Male 
fa12orF 0 35 0 
slightly 
hyponasal, 
slightly 
weak o disordered female 
fa06arF 41 40 1 n/a a disordered female 
nv15arM 25 11 0 n/a a non Male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa17orM 28 45 0 
slight 
nasal air 
emission, 
very 
weak, 
tremulous o disordered Male 
nv19irM 4 10 1 n/a i non Male 
fa19orF 4 33 1 
pitch 
instability o disordered female 
fa08arF 12 0 39 
slightly 
hyponasal, 
tremor, 
pitch 
instability a disordered female 
nv13orF 0 14 0 n/a o non female 
fa18arF 8 53 1 
tremor, 
pitch 
instability, 
weak a disordered Male 
nv19orM 3 8 0 n/a o non Male 
fa23orM 6 56 27 
some 
nasal air 
emission, 
slight 
tremor, 
pitch 
instability o disordered Male 
fa09orM 32 71 48 
Hyponasal
ity o disordered female 
nv12irF 0 11 4 Hypernasal i non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa19arF 19 35 40 
tremor, 
pitch 
instability a Disordered female 
fa23orM2 41 61 54 
inconsiste
nt 
hyponasali
ty, tremor, 
pitch 
instability, 
some 
weakness o disordered Male 
nv01arF 3 8 1 n/a a non female 
fa11orF 13 48 3 
hyponasal, 
pitch 
instability, 
slight 
tremor  o disordered Male 
nv11orM 18 8 4 
slightly 
tremulous o non Male 
fa20orM 39 4 4 
pitch 
instability, 
slightly 
tremulous o non Male 
nv03orF2 0 8 0 n/a o non female 
nv07arF 16 1 30 tremulous a non female 
fa13irF 20 8 68 
hyponasal, 
tremor i disordered female 
nv10arM 22 5 8 n/a a non Male 
fa22orM 11 3 17 
slightly 
hyponasal o non Male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv01orF2 0 5 1 n/a o non female 
nv11arM 27 0 11 Fry a non Male 
fa18irF 1 27 31 
hypernasal
, pitch 
instability i disordered female 
nv09irM 4 0 1 n/a i Non male 
fa25arF 20 1 34 
hypernasal
, slightly 
tremulous, 
pitch 
instability a disordered female 
fa06arF2 5 50 0 
weak 
voice a disordered female 
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Listener 7 
Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa07arM 0 0 0 n/a a non Male 
nv15orM 0 0 0 n/a o non Male 
fa20irM 0 0 0 n/a i non male 
nv08arF 0 0 0 n/a a non female 
fa25irF 0 0 0 n/a i n/a n/a 
fa27irM 0 0 0 n/a i non male 
fa13arF 8 0 3 n/a a non female 
fa07orM2 0 0 0 n/a o non male 
fa23arM 6 0 0 n/a a non male 
nv06irF 0 0 0 n/a i non female 
fa29arM 0 0 0 n/a a non male 
fa06irF 0 8 0 n/a i non female 
fa33arM 0 0 0 n/a a non male 
fa33irM2 0 0 0 n/a i non male 
fa33irM 0 0 0 n/a i non male 
nv04orF 0 0 0 n/a a non female 
fa29irM 0 0 0 n/a i non male 
nv12arF 0 0 0 n/a a non female 
nv05irF2 0 0 0 n/a i non female 
nv03irF 0 0 0 n/a i non female 
nv03orF 0 0 0 n/a o non female 
fa30arM 8 0 0 n/a a non male 
nv07irF 0 0 0 n/a i non female 
nv20irM 0 0 0 n/a i non male 
nv05irF 0 0 0 n/a i non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv02arF 0 0 8 n/a a non female 
fa30irM 0 0 0 n/a i non male 
fa27arM 0 0 0 n/a a non male 
nv18irM 0 0 0 n/a i non male 
nv09arM 0 0 0 n/a a non male 
fa30orM 0 0 0 n/a o non male 
nv01orF 0 0 0 n/a o non female 
fa11irF 0 0 5 n/a i non female 
nv16arM 0 0 0 n/a a non male 
nv10irM 3 0 0 n/a i non male 
fa29orM 0 0 0 n/a a non male 
nv02irF 0 0 0 n/a i non female 
fa19irF 0 0 0 n/a i non female 
nv14arM 0 0 0 n/a a non male 
nv13arF 0 0 0 n/a a non female 
fa27orM 0 0 0 
pitch 
instability o non male 
nv03arF 0 0 0 n/a a non female 
nv10orM 0 0 0 n/a o non male 
nv11irM 0 0 0 n/a i non male 
nv14irM 0 0 0 n/a i non male 
fa23irM 0 17 0 n/a i non male 
nv04arF 0 0 0 n/a a non female 
nv05orF 0 0 0 n/a o non female 
nv08orF 0 0 0 n/a a non female 
nv17irM 0 0 0 n/a i non male 
fa22arM 8 0 0 n/a a non male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv04irF 0 0 0 n/a i non female 
nv17arM 0 0 8 n/a a non male 
nv05arF 0 0 0 n/a a non female 
nv20orM 0 0 0 n/a o non male 
fa18orF 1 1 0 n/a o non female 
nv06arF 0 0 0 n/a a non female 
nv13irF 0 0 0 n/a i non female 
nv02orF 0 0 0 n/a a non female 
nv08orF2 0 0 0 n/a a non female 
fa17arM 0 0 0 n/a a non male 
nv06orF 0 0 0 n/a o non female 
nv08irF 0 0 0 n/a i non female 
fa33orM 0 0 0 n/a o non male 
fa29arM2 0 0 0 n/a a non male 
fa12irF 0 0 0 n/a i non female 
nv07orF 0 0 0 n/a o non female 
nv01irF 0 0 0 n/a i non female 
fa25orF 0 0 0 n/a o non female 
fa20orM2 0 0 0 n/a o non male 
fa11arF 0 0 0 n/a a non female 
nv09orM 0 0 0 n/a o non male 
fa22irM 8 0 0 n/a i non male 
fa20arM 0 0 0 n/a a non male 
nv11orM2 0 0 0 n/a o non male 
fa09arM 0 0 0 n/a a non female 
nv12orF 0 0 0 n/a o non female 
fa17irM 0 14 0 n/a i non male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa13orF 0 0 0 n/a o non female 
nv15orM2 0 0 0 n/a o non male 
fa08irF 0 0 0 n/a i non female 
nv14orM 0 0 0 n/a o non male 
fa10orF 12 0 3 Tremor o disordered female 
fa09irM 4 0 0 
pitch 
instability i disordered female 
nv20arM 0 0 0 n/a a non male 
fa07orM 0 0 0 n/a o non male 
nv15irM 0 0 0 n/a i non male 
fa03irF 0 0 0 n/a i non female 
fa06orF 0 0 0 n/a o non female 
nv19arM 0 0 12 n/a a disordered male 
fa08orF 0 0 0 n/a o non female 
nv16orM 4 0 0 n/a o non male 
fa07irM 0 0 0 n/a i non male 
fa03orF 0 0 0 n/a o non female 
nv17orM 8 0 0 n/a o non male 
fa10irF 0 0 0 n/a i non female 
nv18arM 0 0 0 n/a a non male 
fa10arF 0 0 0 n/a a non female 
fa03arF 0 0 0 n/a a non female 
nv16irM 1 0 0 n/a i non male 
fa12arF 0 0 0 n/a a non female 
nv18orM 0 0 0 n/a o non male 
fa12orF 0 0 0 n/a u non female 
fa06arF 0 0 0 n/a a non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv15arM 0 0 0 n/a a non male 
fa17orM 0 0 0 Tremor o non male 
nv19irM 0 0 0 n/a i non male 
fa19orF 0 0 0 n/a o non female 
fa08arF 0 0 0 n/a a non female 
nv13orF 0 0 0 n/a o non female 
fa18arF 0 3 0 n/a a non male 
nv19orM 0 0 0 n/a a non male 
fa23orM 0 0 0 n/a o non male 
fa09orM 6 2 0 n/a o disordered female 
nv12irF 0 0 0 n/a i non female 
fa19arF 18 0 0 n/a a non female 
fa23orM2 0 0 0 n/a o non male 
nv01arF 0 0 0 n/a a non female 
fa11orF 1 1 0 n/a a non male 
nv11orM 0 0 0 n/a a non male 
fa20orM 0 0 0 n/a o non male 
nv03orF2 0 0 0 n/a o non female 
nv07arF 0 0 0 n/a a non female 
fa13irF 0 0 0 
pitch 
instability i non female 
nv10arM 0 0 0 n/a a non male 
fa22orM 0 0 0 n/a a non male 
nv01orF2 0 3 0 n/a o non female 
nv11arM 0 0 0 Tremor a non male 
fa18irF 0 0 0 n/a i non female 
nv09irM 0 0 0 n/a i non male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa25arF 6 0 0 n/a a non female 
fa06arF2 0 7 0 n/a a non female 
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Listener 8 
Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
fa07arM 16 13 9 n/a a disordered male 
nv15orM 0 0 0 n/a o non male 
fa20irM 3 0 0 n/a i non male 
nv08arF 0 0 0 n/a a non female 
fa25irF 16 1 2 n/a i non male 
fa27irM 4 0 0 
lower 
pitch i non female 
fa13arF 3 34 1 n/a o disordered male 
fa07orM2 3 20 10 n/a a disordered female 
fa23arM 49 45 43 n/a a disordered male 
nv06irF 0 0 0 n/a i non female 
fa29arM 8 0 0 n/a a n/a male 
fa06irF 0 3 3 n/a i non female 
fa33arM 26 0 2 n/a a non male 
fa33irM2 1 0 0 n/a i non Male 
fa33irM 1 0 0 n/a i non Male 
nv04orF 0 0 0 n/a a non Female 
fa29irM 58 12 57 n/a i disordered Male 
nv12arF 0 0 1 n/a a non female 
nv05irF2 0 0 0 n/a i non female 
nv03irF 0 0 0 n/a i non female 
nv03orF 1 0 1 n/a o non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa30arM 44 49 47 n/a a disordered male 
nv07irF 1 1 1 n/a i non female 
nv20irM 0 0 0 
slightly 
high pitch 
for gender i non male 
nv05irF 0 0 0 n/a i non female 
nv02arF 3 1 5 n/a a non female 
fa30irM 25 30 25 n/a i disordered male 
fa27arM 6 1 5 n/a a n/a male 
nv18irM 24 24 22 n/a i disordered male 
nv09arM 20 35 36 n/a a disordered male 
fa30orM 46 44 44 
slight 
tremor o disordered male 
nv01orF 3 49 43 n/a o disordered female 
fa11irF 49 41 60 n/a I disordered male 
nv16arM 12 2 22 n/a a non male 
nv10irM 7 1 2 n/a I non male 
fa29orM 13 3 22 n/a o non male 
nv02irF 0 3 3 n/a i non female 
fa19irF 1 1 36 n/a i disordered female 
nv14arM 1 0 1 n/a a non male 
nv13arF 3 1 1 n/a a non female 
fa27orM 34 18 31 n/a o disordered male 
nv03arF 0 0 0 n/a a non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv10orM 9 1 21 n/a o n/a male 
nv11irM 2 0 3 n/a i non male 
nv14irM 21 1 21 n/a i non male 
fa23irM 58 61 56 n/a i disordered male 
nv04arF 0 0 2 n/a a non female 
nv05orF 0 0 0 n/a o non female 
nv08orF 0 0 0 n/a o non female 
nv17irM 20 2 8 n/a i non male 
fa22arM 35 43 30 n/a a disordered male 
nv04irF 0 0 0 n/a i non female 
nv17arM 26 14 37 n/a a disordered male 
nv05arF 0 0 0 n/a a non female 
nv20orM 0 0 0 n/a o non male 
fa18orF 9 0 1 
lower 
pitch than 
expected o disordered female 
nv06arF 0 2 2 n/a n/a n/a n/a 
nv13irF 1 1 11 n/a i n/a female 
nv02orF 1 1 15 n/a o non female 
nv08orF2 0 0 0 n/a o non female 
fa17arM 13 1 1 
slight 
tremor a n/a male 
nv06orF 0 0 0 n/a o non female 
nv08irF 1 1 1 n/a i non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa33orM 4 0 1 n/a o non male 
fa29arM2 20 1 9 n/a a disordered male 
fa12irF 30 27 31 n/a i disordered female 
nv07orF 2 1 1 
lower 
pitch for 
female o non female 
nv01irF 1 1 9 n/a i non female 
fa25orF 5 0 0 
lower 
pitch for 
female o non female 
fa20orM2 46 42 44 n/a o disordered male 
fa11arF 28 1 23 n/a a disordered female 
nv09orM 0 1 0 n/a o non male 
fa22irM 20 23 26 n/a i disordered male 
fa20arM 30 37 34 n/a a disordered male 
nv11orM2 18 0 1 
slight 
tremor o non male 
fa09arM 46 51 47 n/a a disordered female 
nv12orF 0 0 0 n/a o non female 
fa17irM 44 56 54 n/a i disordered male 
fa13orF 57 44 61 n/a o disordered female 
nv15orM2 0 1 1 n/a o non male 
fa08irF 52 5 48 n/a i disordered female 
nv14orM 0 0 0 n/a o non male 
fa10orF 56 45 60 n/a o disordered female 
102 
 
Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa09irM 30 48 63 n/a i disordered female 
nv20arM 0 0 0 n/a a non male 
fa07orM 54 49 54 n/a i disordered male 
nv15irM 0 0 1 n/a i non male 
fa03irF 50 2 35 n/a i disordered female 
fa06orF 9 3 54 n/a i non female 
nv19arM 36 34 7 n/a a disordered male 
fa08orF 19 0 40 n/a o non female 
nv16orM 53 38 50 n/a o disordered male 
fa07irM 47 45 35 n/a i disordered male 
fa03orF 52 10 41 n/a o disordered female 
nv17orM 59 60 54 n/a o disordered male 
fa10irF 0 1 42 n/a i non female 
nv18arM 29 1 31 n/a a disordered male 
fa10arF 8 1 8 n/a a non female 
fa03arF 58 54 52 n/a a disordered female 
nv16irM 4 1 1 n/a i non male 
fa12arF 0 0 8 n/a a non female 
nv18orM 15 0 30 n/a o non male 
fa12orF 0 0 0 n/a o non female 
fa06arF 55 50 49 n/a a disordered female 
nv15arM 1 0 1 n/a a non male 
fa17orM 1 1 8 slight tremor o non male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv19irM 0 0 0 
higher 
pitch for 
male i non male 
fa19orF 0 1 5 n/a o non female 
fa08arF 58 8 57 n/a a disordered female 
nv13orF 1 0 0 n/a o non female 
fa18arF 1 13 15 
higher 
pitch for 
male a disordered male 
nv19orM 0 0 0 n/a a non male 
fa23orM 5 40 56 n/a i disordered n/a 
fa09orM 55 49 58 n/a o disordered female 
nv12irF 0 0 0 n/a i non female 
fa19arF 47 33 54 n/a a disordered female 
fa23orM2 45 44 49 n/a o disordered male 
nv01arF 0 0 1 n/a a non female 
fa11orF 30 0 1 n/a o non male 
nv11orM 0 0 1 
slight 
tremor o non male 
fa20orM 51 1 43 n/a o disordered male 
nv03orF2 0 0 0 n/a o Non female 
nv07arF 0 0 12 
slight 
tremor a Non female 
fa13irF 8 6 45 n/a i disordered female 
nv10arM 1 0 1 n/a a Non male 
104 
 
Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa22orM 0 1 1 n/a o n/a male 
nv01orF2 17 20 23 n/a o disordered female 
nv11arM 28 1 23 n/a a disordered male 
fa18irF 24 14 17 n/a i disordered female 
nv09irM 1 1 1 n/a i Non male 
fa25arF 17 0 19 n/a a Non female 
fa06arF2 59 57 51 n/a a disordered female 
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Listener 9 
Participant Roughness Breathiness Strain Other 
Perceived 
vowel 
IPA 
Disordered 
or Non- Gender 
fa07arM 0 7 0 n/a a Non male 
nv15orM 0 0 0 
pitch 
instability o Non male 
fa20irM 9 0 8 n/a i Non male 
nv08arF 0 0 0 n/a a Non female 
fa25irF 0 0 9 n/a i Non female 
fa27irM 8 0 0 Tremor i disordered male 
fa13arF 29 29 7 diplophonia a disordered female 
fa07orM2 0 13 0 
diplophonia, 
pitch 
instability o disordered male 
fa23arM 29 0 61 n/a a disordered male 
nv06irF 2 0 0 n/a i Non female 
fa29arM 13 13 0 n/a a Non male 
fa06irF 0 0 0 hypernasal i Non female 
fa33arM 29 0 8 n/a ^ Non male 
fa33irM2 0 0 8 n/a i Non male 
fa33irM 0 0 8 n/a i Non male 
nv04orF 7 8 0 n/a a Non female 
fa29irM 25 30 30 n/a i disordered male 
nv12arF 0 0 0 
pitch 
instability a Non female 
nv05irF2 5 1 0 
mild pitch 
instability i Non female 
nv03irF 8 4 7 n/a i Non female 
nv03orF 0 0 0 n/a o Non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa30arM 40 34 15 pitch inst a disordered male 
nv07irF 6 5 0 n/a i Non female 
nv20irM 0 0 0 n/a i Non male 
nv05irF 1 8 0 
pitch 
instability i Non female 
nv02arF 39 12 22 Tremor a disordered female 
fa30irM 50 49 43 
hypernasal
, tremor i disordered male 
fa27arM 35 21 0 minor fry ^ Non male 
nv18irM 9 9 9 
pitch 
instability i Non male 
nv09arM 8 13 0 n/a a Non male 
fa30orM 56 57 22 n/a o disordered male 
nv01orF 24 23 24 
pitch 
instability o disordered female 
fa11irF 61 53 71 
diplophoni
a, pitch 
instability i disordered male 
nv16arM 50 54 15 Fry a disordered male 
nv10irM 31 32 0 n/a i Non male 
fa29orM 60 58 6 
pitch 
instability u disordered male 
nv02irF 55 50 14 
pitch 
break i disordered female 
fa19irF 58 60 76 
diplophoni
a, tremor i disordered female 
nv14arM 33 16 1 
pitch 
instability a Non male 
nv13arF 31 6 0 n/a a Non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa27orM 24 21 4 
pitch 
instability u Non male 
nv03arF 31 34 9 n/a a Non female 
nv10orM 41 49 0 n/a o disordered male 
nv11irM 38 17 3 
pitch 
instability i Non male 
nv14irM 37 38 40 
pitch 
instability i disordered male 
fa23irM 58 52 64 
diplophoni
a i disordered male 
nv04arF 33 24 14 n/a a Non female 
nv05orF 15 2 0 n/a o Non female 
nv08orF 3 23 0 n/a ^ Non female 
nv17irM 35 17 1 Fry i disordered male 
fa22arM 37 64 38 
diplophoni
a, tremor ^ disordered male 
nv04irF 35 22 10 n/a i Non female 
nv17arM 61 27 50 
pitch 
break a disordered male 
nv05arF 18 29 1 n/a a Non female 
nv20orM 20 4 0 n/a o Non male 
fa18orF 49 68 25 
diplophoni
a o disordered male 
nv06arF 44 36 11 
pitch 
instability a Non female 
nv13irF 38 40 29 
pitch 
instability i disordered female 
nv02orF 57 52 8 Fry o disordered female 
nv08orF2 10 37 0 n/a o Non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa17arM 60 52 60 Tremor a disordered male 
nv06orF 13 17 1 n/a o Non female 
nv08irF 58 45 9 Fry i disordered female 
fa33orM 65 63 53 
pitch inst, 
tremor o disordered male 
fa29arM2 60 70 18 n/a a disordered male 
fa12irF 51 1 0 hypernasal i disordered female 
nv07orF 58 23 1 n/a o disordered female 
nv01irF 50 16 30 n/a i Non female 
fa25orF 25 7 0 n/a o Non female 
fa20orM2 59 52 17 
pitch 
instability o Non male 
fa11arF 76 63 58 
diplophoni
a a disordered female 
nv09orM 12 20 0 n/a o Non male 
fa22irM 66 73 65 Tremor i disordered male 
fa20arM 54 41 34 n/a a Non male 
nv11orM2 39 16 6 
pitch 
instability o Non male 
fa09arM 70 59 75 
diplophoni
a, tremor a disordered female 
nv12orF 24 12 1 n/a o Non female 
fa17irM 61 91 5 Tremor i disordered male 
fa13orF 76 37 57 
pitch 
instability o disordered female 
nv15orM2 38 27 4 n/a o Non male 
fa08irF 78 73 61 
fry, pitch 
instability i disordered female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv14orM 23 9 0 n/a o Non male 
fa10orF 57 63 55 
pitch 
instability o disordered female 
fa09irM 71 64 54 Tremor i disordered female 
nv20arM 14 1 0 n/a a Non male 
fa07orM 88 77 51 
diplophoni
a, tremor o disordered male 
nv15irM 24 8 1 n/a i Non male 
fa03irF 87 76 76 
pitch 
instability i disordered female 
fa06orF 11 40 0 
pitch 
instability o Non female 
nv19arM 61 20 1 Fry a Non male 
fa08orF 62 21 31 
hypernasal
, pitch 
instability o disordered female 
nv16orM 84 48 6 Fry o disordered male 
fa07irM 45 58 14 
pitch 
instability i Non male 
fa03orF 69 51 56 n/a o disordered female 
nv17orM 75 23 1 Fry o disordered male 
fa10irF 46 56 35 Tremor i Non male 
nv18arM 24 1 0 
pitch 
instability a Non male 
fa10arF 63 54 59 
pitch 
instability ^ disordered female 
fa03arF 78 46 65 
pitch 
instability a disordered female 
nv16irM 21 4 0 n/a i Non male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa12arF 31 36 3 n/a a Non female 
nv18orM 27 4 4 n/a o Non male 
fa12orF 47 0 0 hypernasal o disordered female 
fa06arF 79 56 26 Fry a disordered female 
nv15arM 24 12 1 n/a a Non male 
fa17orM 39 60 21 Tremor o disordered male 
nv19irM 19 4 0 n/a i Non male 
fa19orF 59 42 49 
diplophoni
a, pitch 
instability o disordered female 
fa08arF 77 47 60 
fry, pitch 
instability a disordered female 
nv13orF 34 13 1 Fry o Non female 
fa18arF 67 59 29 n/a a disordered male 
nv19orM 27 10 0 n/a o Non male 
fa23orM 60 76 36 
pitch 
instability o disordered male 
fa09orM 65 52 39 
pitch 
instability, 
wet/gurgly o disordered female 
nv12irF 25 3 11 n/a i Non female 
fa19arF 73 62 68 fry, tremor a disordered female 
fa23orM2 61 68 44 Tremor o disordered male 
nv01arF 36 1 19 n/a a Non female 
fa11orF 54 43 33 Tremor o disordered male 
nv11orM 25 39 10 Tremor o disordered male 
fa20orM 39 29 25 
pitch 
instability o Non male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv03orF2 19 1 0 n/a o Non female 
nv07arF 17 19 6 
pitch 
instability a Non female 
fa13irF 43 5 32 hypernasal i disordered female 
nv10arM 18 22 3 n/a a Non male 
fa22orM 36 42 1 n/a o Non male 
nv01orF2 43 49 13 
pitch 
instability o Non female 
nv11arM 29 1 0 
pitch 
instability a Non male 
fa18irF 56 2 43 
hypernasal
, pitch 
instability i disordered female 
nv09irM 25 10 0 n/a i Non male 
fa25arF 38 1 17 
hypernasal
, tremor a disordered female 
fa06arF2 52 88 40 n/a a disordered female 
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Listener 10                 
Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa07arM 5 0 12 n/a a disordered male 
nv15orM 7 0 2 n/a o disordered male 
fa20irM 0 0 27 n/a i disordered male 
nv08arF 3 0 0 n/a a non female 
fa25irF 0 0 43 n/a i disordered male 
fa27irM 27 0 15 
pitch 
instability 
towards 
end i disordered male 
fa13arF 20 43 11 n/a a disordered female 
fa07orM2 22 0 12 
pitch 
instability o disordered male 
fa23arM 21 0 27 
pitch 
instability a disordered male 
nv06irF 0 0 0 n/a i non female 
fa29arM 50 0 6 n/a a disordered male 
fa06irF 0 0 5 
Hypernasa
lity i disordered female 
fa33arM 20 0 34 Fry a disordered male 
fa33irM2 0 0 21 n/a i disordered male 
fa33irM 0 0 21 n/a i disordered male 
nv04orF 0 6 0 n/a a non female 
fa29irM 0 0 15 n/a i disordered male 
nv12arF 7 4 22 n/a a disordered female 
nv05irF2 0 0 5 
pitch 
instability i disordered female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv03irF 0 0 3 n/a i non female 
nv03orF 0 0 7 low pitch o disordered female 
fa30arM 44 24 5 
pitch 
instability a disordered male 
nv07irF 0 20 0 n/a i disordered female 
nv20irM 0 0 0 n/a i non male 
nv05irF 0 0 25 
pitch 
instability i disordered female 
nv02arF 0 0 10 
pitch 
instability a disordered female 
fa30irM 0 15 22 n/a i disordered male 
fa27arM 37 0 0 n/a a disordered male 
nv18irM 12 0 21 n/a i disordered male 
nv09arM 19 0 0 n/a a disordered male 
fa30orM 0 18 0 low pitch o disordered male 
nv01orF 0 25 16 
pitch 
instability o disordered female 
fa11irF 5 8 32 
pitch 
instability i disordered male 
nv16arM 52 0 0 n/a a disordered male 
nv10irM 17 14 0 n/a i disordered male 
fa29orM 15 0 25 n/a o disordered male 
nv02irF 0 4 24 
pitch 
instability i disordered female 
fa19irF 0 0 57 
pitch 
instability i disordered female 
nv14arM 13 0 25 Fry a disordered male 
nv13arF 0 0 18 n/a a disordered female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa27orM 13 0 16 
pitch 
instability o disordered male 
nv03arF 0 0 9 n/a a non female 
nv10orM 19 0 0 n/a o disordered male 
nv11irM 4 0 14 
pitch 
instability i disordered male 
nv14irM 26 0 36 n/a i disordered male 
fa23irM 0 56 0 n/a i disordered male 
nv04arF 0 8 40 n/a a disordered female 
nv05orF 0 0 0 n/a o non female 
nv08orF 0 5 0 n/a o non female 
nv17irM 24 0 31 n/a i disordered male 
fa22arM 24 0 33 n/a a disordered male 
nv04irF 0 15 24 n/a i disordered female 
nv17arM 67 0 31 n/a a disordered male 
nv05arF 0 0 6 n/a a non female 
nv20orM 0 0 11 n/a o non male 
fa18orF 0 37 0 n/a o disordered male 
nv06arF 0 19 15 
pitch 
instability a disordered female 
nv13irF 0 16 27 
pitch 
instability i disordered female 
nv02orF 0 15 23 n/a o disordered female 
nv08orF2 0 4 0 n/a o non female 
fa17arM 23 0 34 
pitch 
instability, 
tremor o disordered male 
nv06orF 0 0 5 n/a o non female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv08irF 12 0 22 n/a i disordered female 
fa33orM 26 0 26 n/a o disordered male 
fa29arM2 50 6 0 n/a a disordered male 
fa12irF 0 0 27 n/a i disordered female 
nv07orF 46 11 11 n/a o disordered female 
nv01irF 0 0 17 n/a i disordered female 
fa25orF 0 0 26 n/a o disordered female 
fa20orM2 33 0 16 
pitch 
instability o disordered male 
fa11arF 23 0 30 n/a a disordered female 
nv09orM 9 0 5 n/a o non male 
fa22irM 0 0 24 
Hypernasa
lity i disordered male 
fa20arM 22 0 21 n/a a disordered male 
nv11orM2 34 0 10 n/a o disordered male 
fa09arM 35 0 31 
pitch 
instability, 
tremor a disordered female 
nv12orF 8 0 0 n/a o non female 
fa17irM 0 53 0 
pitch 
instability i disordered male 
fa13orF 30 0 21 
pitch 
instability o disordered female 
nv15orM2 15 0 16 n/a o disordered male 
fa08irF 0 0 22 n/a i disordered male 
nv14orM 0 0 20 n/a o disordered male 
fa10orF 0 49 41 n/a o disordered male 
fa09irM 26 0 40 n/a i disordered female 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
nv20arM 16 0 42 n/a a disordered male 
fa07orM 15 0 24 
pitch 
instability o disordered male 
nv15irM 5 0 21 n/a i disordered male 
fa03irF 21 0 58 n/a i disordered female 
fa06orF 10 0 17 n/a o disordered female 
nv19arM 33 0 27 
pitch 
instability a disordered male 
fa08orF 0 0 40 
pitch 
instability o disordered male 
nv16orM 54 0 0 n/a o disordered male 
fa07irM 0 17 24 n/a i disordered male 
fa03orF 17 0 26 
pitch 
instability o disordered female 
nv17orM 8 0 18   o disordered male 
fa10irF 0 23 19 n/a i disordered female 
nv18arM 55 0 25 n/a a disordered male 
fa10arF 0 11 26 n/a a disordered female 
fa03arF 45 0 51 n/a a disordered female 
nv16irM 29 0 24 n/a i disordered male 
fa12arF 0 20 0 n/a a disordered female 
nv18orM 13 0 27 n/a o disordered male 
fa12orF 0 24 0 n/a o disordered female 
fa06arF 27 26 0 n/a o disordered female 
nv15arM 38 0 17 n/a a disordered male 
fa17orM 0 35 0 
pitch 
instability o disordered male 
nv19irM 0 0 29 n/a i disordered male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa19orF 0 22 0 
pitch 
instability o disordered female 
fa08arF 52 0 40 n/a a disordered female 
nv13orF 44 0 23 n/a o disordered female 
fa18arF 35 20 0 n/a a disordered male 
nv19orM 0 0 0 n/a a disordered male 
fa23orM 0 0 23 
pitch 
instability o disordered male 
fa09orM 0 13 0 wet/gurgly n/a disordered female 
nv12irF 22 0 25 n/a i disordered female 
fa19arF 24 0 24 
pitch 
instability a disordered female 
fa23orM2 0 0 20 n/a o disordered male 
nv01arF 23 0 20 n/a a disordered female 
fa11orF 37 0 24 n/a o disordered female 
nv11orM 0 0 0 n/a o non male 
fa20orM 16 0 14 n/a o disordered male 
nv03orF2 0 3 0 n/a o non male 
nv07arF 23 0 0 Fry o disordered female 
fa13irF 0 0 33 
pitch 
instability i disordered female 
nv10arM 33 0 0 n/a a disordered male 
fa22orM 0 0 5 n/a o non male 
nv01orF2 0 27 17 
pitch 
instability o disordered female 
nv11arM 30 0 35 n/a o disordered male 
fa18irF 0 24 0 n/a i disordered male 
nv09irM 17 0 23 n/a i disordered male 
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Participant Roughness Breathiness Strain Other 
Perceived 
vowel  
IPA 
Disordered 
or Non- Gender 
fa25arF 0 36 32 n/a a disordered female 
fa06arF2 0 0 52 n/a a non female 
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